[
  {
    "id": 150252,
    "drug": {
      "current_status": "MARKETED",
      "id": 9488,
      "drug_code": 6297,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250873,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00655767",
      "brand_name": "APO-LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62760",
      "number_of_ais": "1",
      "ai_group_no": "0110731002"
    },
    "created_date": "2021-12-01T14:15:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00655767",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-11-29T00:00:00-05:00",
    "actual_end_date": "2021-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-20T13:38:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LORAZEPAM TAB 2MG",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "APO-LORAZEPAM",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150289,
    "drug": {
      "current_status": "MARKETED",
      "id": 24596,
      "drug_code": 87189,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258883,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386313",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2021-12-01T18:50:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386313",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-11-26T00:00:00-05:00",
    "actual_end_date": "2022-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-07-18T20:23:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "Simvastatin",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "Simvastatin",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150316,
    "drug": {
      "current_status": "MARKETED",
      "id": 53479,
      "drug_code": 95068,
      "updated_date": "2025-12-03T00:33:21-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262434,
          "ingredient": {
            "id": 3608,
            "ingredient_code": 20554,
            "en_name": "AZACITIDINE",
            "fr_name": "Azacitidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02462826",
      "brand_name": "AZACITIDINE FOR INJECTION",
      "brand_name_fr": "AZACITIDINE POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152665001"
    },
    "created_date": "2021-12-02T12:20:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02462826",
    "company_name": "DR REDDY'S LABORATORIES LTD",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2021-12-02T00:00:00-05:00",
    "estimated_end_date": "2021-12-30T00:00:00-05:00",
    "actual_start_date": "2021-12-02T00:00:00-05:00",
    "actual_end_date": "2021-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-31T05:22:12-05:00",
    "status": "resolved",
    "en_comments": "Please contact customer service 1-855-550-5528 (Monday to Friday from: 9:00 am to 5:00 pm ET).",
    "fr_comments": "Please contact customer service 1-855-550-5528 (Monday to Friday from: 9:00 am to 5:00 pm ET).",
    "en_drug_brand_name": "AZACITIDINE FOR INJECTION",
    "en_drug_common_name": "AZACITIDINE FOR INJECTION",
    "fr_drug_brand_name": "AZACITIDINE POUR INJECTION",
    "fr_drug_common_name": "AZACITIDINE POUR INJECTION",
    "en_ingredients": "AZACITIDINE",
    "fr_ingredients": "Azacitidine",
    "drug_strength": "100MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1 vial / carton",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150323,
    "drug": {
      "current_status": "MARKETED",
      "id": 7856,
      "drug_code": 51066,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253411,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231689",
      "brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116170002"
    },
    "created_date": "2021-12-02T15:04:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231689",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-11-29T00:00:00-05:00",
    "actual_end_date": "2021-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-30T18:23:44-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "LABETALOL HCL",
    "fr_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "LABETALOL HCL",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "20ML 1LIVI",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150334,
    "drug": {
      "current_status": "MARKETED",
      "id": 15778,
      "drug_code": 76514,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 1240,
        "created_date": "2017-03-09T13:24:00-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11578,
        "mfr_code": "",
        "name": "DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SCHEIJDELVEWEG 2",
        "province": "ZUID-HOLLAND",
        "country": "NETHERLANDS",
        "city": "ZUIDLAND",
        "postal_code": "3214 VN",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255647,
          "ingredient": {
            "id": 3292,
            "ingredient_code": 18848,
            "en_name": "TRYPAN BLUE",
            "fr_name": "Trypan blue"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.06",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279525",
      "brand_name": "VISIONBLUE",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151631001"
    },
    "created_date": "2021-12-02T15:56:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279525",
    "company_name": "DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV",
    "atc_number": "S01KX",
    "atc_description": "SURGICAL AIDS",
    "anticipated_start_date": "2021-11-17T00:00:00-05:00",
    "estimated_end_date": "2022-01-20T00:00:00-05:00",
    "actual_start_date": "2021-11-17T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-20T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "The increased demand for the previous lot, as well as the unexpected delay in the release of the incoming lot together, caused the shortage of this product.  INNOVA Med is working with DORC and HC to try to solve this shortage as quickly as possible.",
    "en_drug_brand_name": "D.O.R.C. VISION BLUE",
    "en_drug_common_name": "TRYPAN BLUE 0.06 % Ophthalmic Solution",
    "fr_drug_brand_name": "D.O.R.C Vision Blue",
    "fr_drug_common_name": "Trypan blue 0.06 %",
    "en_ingredients": "TRYPAN BLUE",
    "fr_ingredients": "Trypan blue",
    "drug_strength": "0.06%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "INTRAOCULAR\r\nINTRAOCULAR",
    "drug_route_fr": "Intraoculaire\r\nIntraoculaire",
    "drug_package_quantity": "0.5 ml/syringes",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150348,
    "drug": {
      "current_status": "MARKETED",
      "id": 54630,
      "drug_code": 95928,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262888,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470306",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548015"
    },
    "created_date": "2021-12-02T16:38:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470306",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2021-12-02T00:00:00-05:00",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-12-02T00:00:00-05:00",
    "actual_end_date": "2021-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-23T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "35MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150351,
    "drug": {
      "current_status": "MARKETED",
      "id": 14304,
      "drug_code": 74388,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255153,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8255152,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02258692",
      "brand_name": "COSOPT PRESERVATIVE-FREE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2021-12-02T16:43:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258692",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2021-12-02T00:00:00-05:00",
    "estimated_end_date": "2021-12-14T00:00:00-05:00",
    "actual_start_date": "2021-12-02T00:00:00-05:00",
    "actual_end_date": "2021-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-18T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "COSOPT",
    "en_drug_common_name": "Dorzolamide and Timolol Ophthalmic solution",
    "fr_drug_brand_name": "Cosopt",
    "fr_drug_common_name": "Collyre de dorzolamide et timolol",
    "en_ingredients": "TIMOLOL\r\nDORZOLAMIDE",
    "fr_ingredients": "Chlorhydrate de dorzolamide et de maleate de timolol",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "0.2ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150354,
    "drug": {
      "current_status": "MARKETED",
      "id": 7246,
      "drug_code": 49057,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253255,
          "ingredient": {
            "id": 1516,
            "ingredient_code": 6750,
            "en_name": "CODEINE",
            "fr_name": "Codéine (Phosphate de codéine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230302",
      "brand_name": "CODEINE CONTIN 50MG CONTROLLED RELEASE TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153086003"
    },
    "created_date": "2021-12-02T16:52:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230302",
    "company_name": "PURDUE PHARMA",
    "atc_number": "R05DA",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "anticipated_start_date": "2021-12-02T00:00:00-05:00",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-12-02T00:00:00-05:00",
    "actual_end_date": "2021-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-22T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CODEINE CONTIN 50MG CONTROLLED RELEASE TAB",
    "en_drug_common_name": "Codeine Controlled Release Tablets",
    "fr_drug_brand_name": "CODEINE CONTIN",
    "fr_drug_common_name": "Comprimés de codéine à libération contrôlée",
    "en_ingredients": "CODEINE",
    "fr_ingredients": "Codéine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150359,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 80,
      "drug_code": 10169,
      "updated_date": "2025-05-15T03:36:52-04:00",
      "company": {
        "id": 30,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 3574,
        "mfr_code": "ALL07",
        "name": "ALLERGAN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "300",
        "street_name": "1380 RODICK ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 4G5",
        "post_office_box": "",
        "contact_information": "Company contact information;\r\nTelephone number: 800-668-6424\r\nEmail address: MR-GENERAL_INQUIRY@allergan.com\r\nWebsite address: allergan.ca\r\nPostal address:  500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5"
      },
      "drug_ingredients": [
        {
          "id": 8286365,
          "ingredient": {
            "id": 70,
            "ingredient_code": 7617,
            "en_name": "PREDNISOLONE ACETATE",
            "fr_name": "Acétate de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8286364,
          "ingredient": {
            "id": 72,
            "ingredient_code": 8145,
            "en_name": "SULFACETAMIDE SODIUM",
            "fr_name": "Sulfacétamide sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00807788",
      "brand_name": "BLEPHAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69880",
      "number_of_ais": "2",
      "ai_group_no": "0206094001"
    },
    "created_date": "2021-12-02T18:38:35-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00807788",
    "company_name": "ALLERGAN INC",
    "atc_number": "S01CA",
    "atc_description": "ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB",
    "anticipated_discontinuation_date": "2022-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-02T18:55:09-05:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "BLEPHAMIDE",
    "en_drug_common_name": "Sulfacetamide/Prednisolone suspension",
    "fr_drug_brand_name": "Blephamide",
    "fr_drug_common_name": "Sulfacétamide/prednisolone",
    "en_ingredients": "PREDNISOLONE ACETATE\r\nSULFACETAMIDE SODIUM",
    "fr_ingredients": "Acétate de prednisolone\r\nSulfacétamide sodique",
    "drug_strength": "0.2%\r\n10%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5mL and 10mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150361,
    "drug": {
      "current_status": "MARKETED",
      "id": 2530,
      "drug_code": 16102,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252087,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02014203",
      "brand_name": "MS.IR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77888",
      "number_of_ais": "1",
      "ai_group_no": "0104545003"
    },
    "created_date": "2021-12-02T18:40:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02014203",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-12-02T00:00:00-05:00",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-12-02T00:00:00-05:00",
    "actual_end_date": "2021-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-22T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MS.IR",
    "en_drug_common_name": "Morphine Sulfate Immediate Release Tablets",
    "fr_drug_brand_name": "MS•IR",
    "fr_drug_common_name": "Comprimés de sulfate de morphine à libération immédiate",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150365,
    "drug": {
      "current_status": "MARKETED",
      "id": 392,
      "drug_code": 10913,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251442,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251441,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00657298",
      "brand_name": "VASERETIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71053",
      "number_of_ais": "2",
      "ai_group_no": "0252326001"
    },
    "created_date": "2021-12-02T19:29:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00657298",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "anticipated_start_date": "2021-12-18T00:00:00-05:00",
    "estimated_end_date": "2022-02-09T00:00:00-05:00",
    "actual_start_date": "2021-12-18T00:00:00-05:00",
    "actual_end_date": "2022-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-02-01T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VASERETIC",
    "en_drug_common_name": "enalapril and hydrochlorothiazide tablets",
    "fr_drug_brand_name": "VASERETIC",
    "fr_drug_common_name": "comprimés d’énalapril et d’hydrochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nENALAPRIL SODIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nÉnalapril sodique",
    "drug_strength": "25MG\r\n8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150376,
    "drug": {
      "current_status": "MARKETED",
      "id": 8944,
      "drug_code": 61290,
      "updated_date": "2025-12-03T00:30:40-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8253548,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237925",
      "brand_name": "AVAPRO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700003"
    },
    "created_date": "2021-12-02T20:02:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237925",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2021-12-31T00:00:00-05:00",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_end_date": "2022-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-09T19:34:19-04:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "AVAPRO",
    "en_drug_common_name": "Avapro",
    "fr_drug_brand_name": "AVAPRO",
    "fr_drug_common_name": "Avapro",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150385,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20820,
      "drug_code": 82690,
      "updated_date": "2025-05-15T04:15:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348229,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341387",
      "brand_name": "PMS-FENTANYL MTX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302014"
    },
    "created_date": "2021-12-02T20:26:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341387",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2021-12-01T00:00:00-05:00",
    "actual_end_date": "2022-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-07T20:05:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-FENTANYL MTX",
    "en_drug_common_name": "FENTANYL MTX",
    "fr_drug_brand_name": "PMS-FENTANYL MTX",
    "fr_drug_common_name": "FENTANYL MTX",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "25MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150400,
    "drug": {
      "current_status": "MARKETED",
      "id": 100147,
      "drug_code": 98436,
      "updated_date": "2020-04-03T06:54:26-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264619,
          "ingredient": {
            "id": 1178,
            "ingredient_code": 9954,
            "en_name": "LIOTHYRONINE",
            "fr_name": "Liothyronine (Liothyronine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02494337",
      "brand_name": "TEVA-LIOTHYRONINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102421001"
    },
    "created_date": "2021-12-02T20:59:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02494337",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-11-30T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-20T14:40:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LIOTHYRONINE",
    "en_drug_common_name": "LIOTHYRONINE 5MCG TAB",
    "fr_drug_brand_name": "TEVA-LIOTHYRONINE 5MCG TAB",
    "fr_drug_common_name": "LIOTHYRONINE 5MCG TAB",
    "en_ingredients": "LIOTHYRONINE",
    "fr_ingredients": "LIOTHYRONINE",
    "drug_strength": "5MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150403,
    "drug": {
      "current_status": "MARKETED",
      "id": 11066,
      "drug_code": 67216,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254157,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "375",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243313",
      "brand_name": "TEVA-NAPROXEN EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634004"
    },
    "created_date": "2021-12-02T21:00:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243313",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-02-28T00:00:00-05:00",
    "actual_start_date": "2021-11-30T00:00:00-05:00",
    "actual_end_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-10T19:25:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NAPROXEN EC",
    "en_drug_common_name": "NAPROXEN-EC 375MG TAB",
    "fr_drug_brand_name": "TEVA-NAPROXEN-EC 375MG TAB",
    "fr_drug_common_name": "NAPROXEN-EC 375MG TAB",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "375MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150406,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 65754,
      "drug_code": 95837,
      "updated_date": "2025-12-03T01:33:34-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357588,
          "ingredient": {
            "id": 3710,
            "ingredient_code": 20671,
            "en_name": "FINGOLIMOD",
            "fr_name": "Fingolimod (Chlorhydrate de Fingolimod)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02469561",
      "brand_name": "TEVA-FINGOLIMOD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152886001"
    },
    "created_date": "2021-12-02T21:01:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469561",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_start_date": "2021-11-30T00:00:00-05:00",
    "actual_end_date": "2022-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-05T16:52:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FINGOLIMOD",
    "en_drug_common_name": "FINGOLIMOD 0.5MG CAPS",
    "fr_drug_brand_name": "TEVA-FINGOLIMOD 0.5MG CAPS",
    "fr_drug_common_name": "FINGOLIMOD 0.5MG CAPS",
    "en_ingredients": "FINGOLIMOD",
    "fr_ingredients": "FINGOLIMOD",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 Blis",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150409,
    "drug": {
      "current_status": "MARKETED",
      "id": 16428,
      "drug_code": 77228,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255860,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286823",
      "brand_name": "TEVA-SUMATRIPTAN DF",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238002"
    },
    "created_date": "2021-12-02T21:02:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286823",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2023-02-10T00:00:00-05:00",
    "actual_start_date": "2021-11-30T00:00:00-05:00",
    "actual_end_date": "2023-01-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-26T19:50:35-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SUMATRIPTAN DF",
    "en_drug_common_name": "SUMATRIPTAN DF 50MG TAB",
    "fr_drug_brand_name": "TEVA-SUMATRIPTAN DF 50MG TAB",
    "fr_drug_common_name": "SUMATRIPTAN DF 50MG TAB",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150414,
    "drug": {
      "current_status": "MARKETED",
      "id": 21028,
      "drug_code": 83255,
      "updated_date": "2025-12-03T00:31:35-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257459,
          "ingredient": {
            "id": 3532,
            "ingredient_code": 20437,
            "en_name": "LISDEXAMFETAMINE DIMESYLATE",
            "fr_name": "Dimésylate de lisdexamfétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347164",
      "brand_name": "VYVANSE",
      "brand_name_fr": "VYVANSE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152536004"
    },
    "created_date": "2021-12-03T01:15:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347164",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2021-12-02T00:00:00-05:00",
    "estimated_end_date": "2021-12-17T00:00:00-05:00",
    "actual_start_date": "2021-12-02T00:00:00-05:00",
    "actual_end_date": "2021-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-12T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VYVANSE",
    "en_drug_common_name": "Lisdexamfetamine dimesylate capsules",
    "fr_drug_brand_name": "VYVANSE",
    "fr_drug_common_name": "Gélules de dimésylate de lisdexamfétamine",
    "en_ingredients": "LISDEXAMFETAMINE DIMESYLATE",
    "fr_ingredients": "Dimésylate de lisdexamfétamine",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150417,
    "drug": {
      "current_status": "MARKETED",
      "id": 19516,
      "drug_code": 80843,
      "updated_date": "2025-12-03T00:31:24-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256819,
          "ingredient": {
            "id": 3532,
            "ingredient_code": 20437,
            "en_name": "LISDEXAMFETAMINE DIMESYLATE",
            "fr_name": "Dimésylate de lisdexamfétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02322951",
      "brand_name": "VYVANSE",
      "brand_name_fr": "VYVANSE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152536001"
    },
    "created_date": "2021-12-03T01:28:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02322951",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2021-12-02T00:00:00-05:00",
    "estimated_end_date": "2021-12-17T00:00:00-05:00",
    "actual_start_date": "2021-12-02T00:00:00-05:00",
    "actual_end_date": "2021-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-12T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VYVANSE",
    "en_drug_common_name": "Lisdexamfetamine dimesylate capsules",
    "fr_drug_brand_name": "VYVANSE",
    "fr_drug_common_name": "Gélules de dimésylate de lisdexamfétamine",
    "en_ingredients": "LISDEXAMFETAMINE DIMESYLATE",
    "fr_ingredients": "Dimésylate de lisdexamfétamine",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150420,
    "drug": {
      "current_status": "MARKETED",
      "id": 21030,
      "drug_code": 83256,
      "updated_date": "2025-12-03T00:31:35-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257460,
          "ingredient": {
            "id": 3532,
            "ingredient_code": 20437,
            "en_name": "LISDEXAMFETAMINE DIMESYLATE",
            "fr_name": "Dimésylate de lisdexamfétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347172",
      "brand_name": "VYVANSE",
      "brand_name_fr": "VYVANSE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152536005"
    },
    "created_date": "2021-12-03T01:32:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347172",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2021-12-02T00:00:00-05:00",
    "estimated_end_date": "2021-12-02T00:00:00-05:00",
    "actual_start_date": "2021-12-02T00:00:00-05:00",
    "actual_end_date": "2021-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-12T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VYVANSE",
    "en_drug_common_name": "Lisdexamfetamine dimesylate capsules",
    "fr_drug_brand_name": "VYVANSE",
    "fr_drug_common_name": "Gélules de dimésylate de lisdexamfétamine",
    "en_ingredients": "LISDEXAMFETAMINE DIMESYLATE",
    "fr_ingredients": "Dimésylate de lisdexamfétamine",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150423,
    "drug": {
      "current_status": "MARKETED",
      "id": 64734,
      "drug_code": 98028,
      "updated_date": "2025-12-03T00:34:29-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264235,
          "ingredient": {
            "id": 3532,
            "ingredient_code": 20437,
            "en_name": "LISDEXAMFETAMINE DIMESYLATE",
            "fr_name": "Dimésylate de lisdexamfétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02490226",
      "brand_name": "VYVANSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152536006"
    },
    "created_date": "2021-12-03T01:49:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02490226",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2021-12-02T00:00:00-05:00",
    "estimated_end_date": "2021-12-17T00:00:00-05:00",
    "actual_start_date": "2021-12-02T00:00:00-05:00",
    "actual_end_date": "2021-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-12T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VYVANSE",
    "en_drug_common_name": "Lisdexamfetamine dimesylate chewable tablets",
    "fr_drug_brand_name": "VYVANSE",
    "fr_drug_common_name": "Comprimés à croquer de dimésylate de lisdexamfétamine",
    "en_ingredients": "LISDEXAMFETAMINE DIMESYLATE",
    "fr_ingredients": "Dimésylate de lisdexamfétamine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150432,
    "drug": {
      "current_status": "MARKETED",
      "id": 63458,
      "drug_code": 97555,
      "updated_date": "2025-05-15T02:37:29-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8263875,
          "ingredient": {
            "id": 3356,
            "ingredient_code": 20022,
            "en_name": "DEFERASIROX",
            "fr_name": "Déférasirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "360",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02485281",
      "brand_name": "APO-DEFERASIROX (TYPE J)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151733006"
    },
    "created_date": "2021-12-03T13:26:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485281",
    "company_name": "APOTEX INC",
    "atc_number": "V03AC",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2022-01-02T00:00:00-05:00",
    "actual_start_date": "2021-11-29T00:00:00-05:00",
    "actual_end_date": "2021-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-20T13:33:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DEFERASIROX (TYPE J)",
    "en_drug_common_name": "DEFERASIROX",
    "fr_drug_brand_name": "APO-DEFERASIROX",
    "fr_drug_common_name": "DEFERASIROX",
    "en_ingredients": "DEFERASIROX",
    "fr_ingredients": "Déférasirox",
    "drug_strength": "360MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150435,
    "drug": {
      "current_status": "MARKETED",
      "id": 16844,
      "drug_code": 77826,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255946,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292912",
      "brand_name": "APO-PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229002"
    },
    "created_date": "2021-12-03T13:31:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292912",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-02-18T00:00:00-05:00",
    "actual_start_date": "2021-11-29T00:00:00-05:00",
    "actual_end_date": "2022-02-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-14T13:28:55-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PANTOPRAZOLE",
    "en_drug_common_name": "PANTOPRAZOLE",
    "fr_drug_brand_name": "APO-PANTOPRAZOLE",
    "fr_drug_common_name": "PANTOPRAZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150440,
    "drug": {
      "current_status": "MARKETED",
      "id": 20522,
      "drug_code": 82237,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257264,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02336758",
      "brand_name": "APO-RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521004"
    },
    "created_date": "2021-12-03T13:36:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02336758",
    "company_name": "APOTEX INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2022-02-13T00:00:00-05:00",
    "actual_start_date": "2021-11-29T00:00:00-05:00",
    "actual_end_date": "2021-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-13T13:29:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "APO-RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "6MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150445,
    "drug": {
      "current_status": "MARKETED",
      "id": 10010,
      "drug_code": 64427,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253810,
          "ingredient": {
            "id": 2000,
            "ingredient_code": 11282,
            "en_name": "SALMETEROL",
            "fr_name": "Salmétérol (Xinafoate de salmétérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8253809,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02240836",
      "brand_name": "ADVAIR 250 DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0238341002"
    },
    "created_date": "2021-12-03T15:13:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240836",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2022-01-04T00:00:00-05:00",
    "actual_start_date": "2021-11-29T00:00:00-05:00",
    "actual_end_date": "2022-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-05T19:45:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ADVAIR 250 DISKUS",
    "en_drug_common_name": "fluticasone propionate and salmeterol inhalation powder",
    "fr_drug_brand_name": "ADVAIR 250 DISKUS",
    "fr_drug_common_name": "propionate de fluticasone et salmétérol en poudre pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE\r\nSALMETEROL",
    "fr_ingredients": "Propionate de fluticasone; Salmétérol",
    "drug_strength": "250MCG\r\n50MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "60s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150448,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7958,
      "drug_code": 5168,
      "updated_date": "2025-12-03T01:01:12-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8278061,
          "ingredient": {
            "id": 346,
            "ingredient_code": 5054,
            "en_name": "TRETINOIN",
            "fr_name": "Trétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00578576",
      "brand_name": "STIEVA-A",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59831",
      "number_of_ais": "1",
      "ai_group_no": "0112395002"
    },
    "created_date": "2021-12-03T15:20:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00578576",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2022-03-29T00:00:00-04:00",
    "actual_start_date": "2021-11-29T00:00:00-05:00",
    "actual_end_date": "2022-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-09T18:04:19-05:00",
    "status": "resolved",
    "en_comments": "Limited supply currently available.",
    "fr_comments": "Une quantité limitée est disponible en ce moment.",
    "en_drug_brand_name": "STIEVA-A",
    "en_drug_common_name": "Tretinoin cream",
    "fr_drug_brand_name": "STIEVA-A",
    "fr_drug_common_name": "Crème de trétinoïne",
    "en_ingredients": "TRETINOIN",
    "fr_ingredients": "Trétinoïne",
    "drug_strength": "0.025%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "25G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150453,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18486,
      "drug_code": 79757,
      "updated_date": "2025-05-15T04:13:53-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345620,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02312050",
      "brand_name": "PRO-PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541001"
    },
    "created_date": "2021-12-03T15:34:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02312050",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2022-03-03T00:00:00-05:00",
    "actual_start_date": "2022-03-03T00:00:00-05:00",
    "actual_end_date": "2022-07-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-15T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement",
    "fr_comments": "Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement",
    "en_drug_brand_name": "PRO-PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "PRO- PIOGLITAZONE",
    "fr_drug_common_name": "PIOGLITAZONE",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150456,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18488,
      "drug_code": 79758,
      "updated_date": "2025-05-15T04:13:53-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345621,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02312069",
      "brand_name": "PRO-PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541002"
    },
    "created_date": "2021-12-03T15:37:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02312069",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2022-05-30T00:00:00-04:00",
    "actual_end_date": "2022-07-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-15T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement",
    "fr_comments": "Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement",
    "en_drug_brand_name": "PRO-PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "PRO- PIOGLITAZONE",
    "fr_drug_common_name": "PIOGLITAZONE",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150459,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18490,
      "drug_code": 79759,
      "updated_date": "2025-05-15T04:13:53-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345622,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02312077",
      "brand_name": "PRO-PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541003"
    },
    "created_date": "2021-12-03T15:42:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02312077",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2021-12-31T00:00:00-05:00",
    "actual_start_date": "2022-01-06T00:00:00-05:00",
    "actual_end_date": "2022-07-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-15T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement",
    "fr_comments": "Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement",
    "en_drug_brand_name": "PRO-PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "PRO- PIOGLITAZONE",
    "fr_drug_common_name": "PIOGLITAZONE",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "45MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150486,
    "drug": {
      "current_status": "MARKETED",
      "id": 2226,
      "drug_code": 14735,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8251992,
          "ingredient": {
            "id": 1106,
            "ingredient_code": 6506,
            "en_name": "HYDROXYCHLOROQUINE SULFATE",
            "fr_name": "Sulfate d'hydroxychloroquine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02017709",
      "brand_name": "PLAQUENIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76405",
      "number_of_ais": "1",
      "ai_group_no": "0107403001"
    },
    "created_date": "2021-12-06T13:37:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02017709",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "P01BA",
    "atc_description": "ANTIMALARIALS",
    "anticipated_start_date": "2021-12-09T00:00:00-05:00",
    "estimated_end_date": "2022-01-06T00:00:00-05:00",
    "actual_start_date": "2021-12-09T00:00:00-05:00",
    "actual_end_date": "2022-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-07T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "PLAQUENIL",
    "en_drug_common_name": "Plaquenil",
    "fr_drug_brand_name": "PLAQUENIL",
    "fr_drug_common_name": "Plaquenil",
    "en_ingredients": "HYDROXYCHLOROQUINE SULFATE",
    "fr_ingredients": "Sulfate d'hydroxychloroquine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150508,
    "drug": {
      "current_status": "MARKETED",
      "id": 200,
      "drug_code": 10511,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251349,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060348",
      "brand_name": "5% DEXTROSE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70437",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2021-12-06T18:39:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060348",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-12-06T00:00:00-05:00",
    "estimated_end_date": "2022-09-16T00:00:00-04:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-17T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "en_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "5G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL (JB0040)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150511,
    "drug": {
      "current_status": "MARKETED",
      "id": 200,
      "drug_code": 10511,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251349,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060348",
      "brand_name": "5% DEXTROSE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70437",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2021-12-06T18:42:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060348",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-12-06T00:00:00-05:00",
    "estimated_end_date": "2022-09-01T00:00:00-04:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-02T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "en_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "5G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100 mL (JB0041P)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150514,
    "drug": {
      "current_status": "MARKETED",
      "id": 200,
      "drug_code": 10511,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251349,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060348",
      "brand_name": "5% DEXTROSE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70437",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2021-12-06T18:45:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060348",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-12-06T00:00:00-05:00",
    "estimated_end_date": "2022-08-23T00:00:00-04:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-08-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-24T05:00:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "en_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "5G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250 mL (JB0048)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150517,
    "drug": {
      "current_status": "MARKETED",
      "id": 34,
      "drug_code": 10040,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251278,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060208",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69686",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-12-06T18:48:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060208",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2021-12-06T00:00:00-05:00",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-07-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "fr_drug_brand_name": "Chlorure de sodium injectable à 0,9 %, USP",
    "fr_drug_common_name": "Chlorure de sodium injectable à 0,9 %, USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL (JB0042)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150520,
    "drug": {
      "current_status": "MARKETED",
      "id": 34,
      "drug_code": 10040,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251278,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060208",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69686",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-12-06T18:52:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060208",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2021-12-06T00:00:00-05:00",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-07-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "fr_drug_brand_name": "Chlorure de sodium injectable à 0,9 %, USP",
    "fr_drug_common_name": "Chlorure de sodium injectable à 0,9 %, USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100 mL (JB0043P)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150523,
    "drug": {
      "current_status": "MARKETED",
      "id": 34,
      "drug_code": 10040,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251278,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060208",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69686",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-12-06T18:54:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060208",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2021-12-06T00:00:00-05:00",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-07-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "fr_drug_brand_name": "Chlorure de sodium injectable à 0,9 %, USP",
    "fr_drug_common_name": "Chlorure de sodium injectable à 0,9 %, USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250 mL (JB0049)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150544,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10592,
      "drug_code": 66172,
      "updated_date": "2025-12-03T01:19:25-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8332470,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242453",
      "brand_name": "PMS-RANITIDINE 150 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2021-12-06T19:23:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242453",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "hc_updated_date": "2022-12-06T19:53:40-05:00",
    "actual_start_date": "2019-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-06T19:53:43-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150547,
    "drug": {
      "current_status": "MARKETED",
      "id": 6218,
      "drug_code": 430,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250152,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00030937",
      "brand_name": "PROVERA 5MG TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "15524",
      "number_of_ais": "1",
      "ai_group_no": "0106339005"
    },
    "created_date": "2021-12-06T20:26:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00030937",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2022-07-18T00:00:00-04:00",
    "actual_start_date": "2021-12-01T00:00:00-05:00",
    "actual_end_date": "2022-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-01T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Remaining inventory under preventative allocation. Partial replenishment to be available mid-January 2022.",
    "fr_comments": "L’inventaire disponible est en allocation préventive. Un réapprovisionnement partiel sera disponible vers la mi-janvier 2022.",
    "en_drug_brand_name": "PROVERA 5MG TABLETS",
    "en_drug_common_name": "PROVERA",
    "fr_drug_brand_name": "PROVERA 5MG",
    "fr_drug_common_name": "PROVERA",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150550,
    "drug": {
      "current_status": "MARKETED",
      "id": 14524,
      "drug_code": 7480,
      "updated_date": "2025-05-15T02:30:40-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251021,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00729973",
      "brand_name": "PROVERA 10MG TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65546",
      "number_of_ais": "1",
      "ai_group_no": "0106339006"
    },
    "created_date": "2021-12-06T20:28:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00729973",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2023-03-06T00:00:00-05:00",
    "actual_start_date": "2021-12-17T00:00:00-05:00",
    "actual_end_date": "2022-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-01T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Remaining inventory under preventative allocation.",
    "fr_comments": "L’inventaire disponible est en allocation préventive.",
    "en_drug_brand_name": "PROVERA 10MG TABLETS",
    "en_drug_common_name": "PROVERA",
    "fr_drug_brand_name": "PROVERA 10MG",
    "fr_drug_common_name": "PROVERA",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150553,
    "drug": {
      "current_status": "MARKETED",
      "id": 1416,
      "drug_code": 13037,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251719,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00708917",
      "brand_name": "PROVERA 2.5MG TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74299",
      "number_of_ais": "1",
      "ai_group_no": "0106339004"
    },
    "created_date": "2021-12-06T20:35:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00708917",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2022-05-23T00:00:00-04:00",
    "actual_start_date": "2021-12-17T00:00:00-05:00",
    "actual_end_date": "2022-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-01T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Remaining inventory under preventative allocation.",
    "fr_comments": "L’inventaire disponible est en allocation préventive.",
    "en_drug_brand_name": "PROVERA 2.5MG TABLETS",
    "en_drug_common_name": "PROVERA",
    "fr_drug_brand_name": "PROVERA 2.5MG",
    "fr_drug_common_name": "PROVERA",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150576,
    "drug": {
      "current_status": "MARKETED",
      "id": 12268,
      "drug_code": 70531,
      "updated_date": "2025-05-15T02:31:21-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254521,
          "ingredient": {
            "id": 1368,
            "ingredient_code": 1988,
            "en_name": "TRANEXAMIC ACID",
            "fr_name": "Acide tranexamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02246365",
      "brand_name": "TRANEXAMIC ACID INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114760002"
    },
    "created_date": "2021-12-07T01:42:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246365",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B02AA",
    "atc_description": "ANTIFIBRINOLYTICS",
    "estimated_end_date": "2021-12-10T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2021-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-20T16:16:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TRANEXAMIC ACID INJECTION BP",
    "en_drug_common_name": "TRANEXAMIC ACID",
    "fr_drug_brand_name": "TRANEXAMIC ACID INJECTION BP",
    "fr_drug_common_name": "TRANEXAMIC ACID",
    "en_ingredients": "TRANEXAMIC ACID",
    "fr_ingredients": "Acide tranexamique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150579,
    "drug": {
      "current_status": "MARKETED",
      "id": 18324,
      "drug_code": 79599,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256423,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310341",
      "brand_name": "SANDOZ OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783001"
    },
    "created_date": "2021-12-07T01:44:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310341",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-12-17T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2021-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-21T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "SANDOZ OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150582,
    "drug": {
      "current_status": "MARKETED",
      "id": 22006,
      "drug_code": 84365,
      "updated_date": "2025-05-15T02:32:49-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257872,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "SACHET",
          "base": false
        }
      ],
      "din": "02358611",
      "brand_name": "SANDOZ MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823003"
    },
    "created_date": "2021-12-07T01:46:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02358611",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "estimated_end_date": "2022-02-11T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-18T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MONTELUKAST GRANULES",
    "en_drug_common_name": "MONTELUKAST GRANULES",
    "fr_drug_brand_name": "SANDOZ MONTELUKAST GRANULES",
    "fr_drug_common_name": "MONTELUKAST GRANULES",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "4MG",
    "drug_dosage_form": "GRANULES",
    "drug_dosage_form_fr": "Granules",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30OGR",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150586,
    "drug": {
      "current_status": "MARKETED",
      "id": 19936,
      "drug_code": 81247,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256970,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02327155",
      "brand_name": "SANDOZ FENTANYL PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302013"
    },
    "created_date": "2021-12-07T01:49:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327155",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:36:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "en_drug_common_name": "FENTANYL PATCH",
    "fr_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "fr_drug_common_name": "FENTANYL PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "75MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5TTSS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150589,
    "drug": {
      "current_status": "MARKETED",
      "id": 19930,
      "drug_code": 81244,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256967,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02327120",
      "brand_name": "SANDOZ FENTANYL PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302014"
    },
    "created_date": "2021-12-07T01:51:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327120",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-01-28T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-02T03:11:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "en_drug_common_name": "FENTANYL PATCH",
    "fr_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "fr_drug_common_name": "FENTANYL PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "25MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5TTSS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150608,
    "drug": {
      "current_status": "MARKETED",
      "id": 32178,
      "drug_code": 9892,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251241,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251240,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251239,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00821373",
      "brand_name": "COTAZYM ECS 20",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69249",
      "number_of_ais": "3",
      "ai_group_no": "0302964026"
    },
    "created_date": "2021-12-07T18:37:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00821373",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "estimated_end_date": "2021-12-10T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2021-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-11T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "COTAZYM ECS 20",
    "en_drug_common_name": "PANCRELIPASE DELAYED-RELEASE CAPSULES",
    "fr_drug_brand_name": "COTAZYM E.C.S.",
    "fr_drug_common_name": "CAPSULES DE PANCRÉLIPASE À LIBÉRATION RETARDÉE",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "100000UNIT\r\n100000UNIT\r\n25000UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150613,
    "drug": {
      "current_status": "MARKETED",
      "id": 51759,
      "drug_code": 95265,
      "updated_date": "2025-05-15T02:35:52-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262531,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8262530,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02464519",
      "brand_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561001"
    },
    "created_date": "2021-12-07T19:06:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464519",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_start_date": "2021-12-01T00:00:00-05:00",
    "actual_end_date": "2022-03-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-12T15:46:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
    "en_drug_common_name": "Taro BP/Clinda Kit",
    "fr_drug_brand_name": "TARO\tBENZOYL 5% GL/CLINDAMYCIN 1% SL 50G",
    "fr_drug_common_name": "Taro BP/Clinda Kit",
    "en_ingredients": "BENZOYL PEROXIDE\r\nCLINDAMYCIN",
    "fr_ingredients": "Peroxyde de benzoyle",
    "drug_strength": "5%\r\n1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150620,
    "drug": {
      "current_status": "MARKETED",
      "id": 22684,
      "drug_code": 85224,
      "updated_date": "2025-12-03T00:31:47-05:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258177,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02367394",
      "brand_name": "TARO-CARBAMAZEPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108674002"
    },
    "created_date": "2021-12-07T19:11:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367394",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "N03AF",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2021-10-20T00:00:00-04:00",
    "actual_end_date": "2022-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T14:13:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CARBAMAZEPINE",
    "en_drug_common_name": "CARBAMAZEPINE SUSPENSION",
    "fr_drug_brand_name": "TARO-CARBAMAZEPINE",
    "fr_drug_common_name": "CARBAMAZEPINE SUSP",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "100MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "450ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150629,
    "drug": {
      "current_status": "MARKETED",
      "id": 25080,
      "drug_code": 87587,
      "updated_date": "2025-05-15T02:33:37-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259091,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02390450",
      "brand_name": "TARO-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752004"
    },
    "created_date": "2021-12-07T19:15:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390450",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2022-02-25T00:00:00-05:00",
    "actual_start_date": "2021-11-26T00:00:00-05:00",
    "actual_end_date": "2022-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-12T15:37:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "TARO-CLARITHROMYCIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "105ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150632,
    "drug": {
      "current_status": "MARKETED",
      "id": 11864,
      "drug_code": 69609,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254397,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245522",
      "brand_name": "TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2021-12-07T19:18:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245522",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2021-12-17T00:00:00-05:00",
    "actual_start_date": "2021-11-16T00:00:00-05:00",
    "actual_end_date": "2021-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-06T20:45:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150635,
    "drug": {
      "current_status": "MARKETED",
      "id": 101083,
      "drug_code": 99554,
      "updated_date": "2020-11-09T00:55:04-05:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265672,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02506203",
      "brand_name": "TARO-CLOBETASOL SHAMPOO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2021-12-07T19:20:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02506203",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-16T03:46:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL SHAMPOO",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "SHAMPOO",
    "drug_dosage_form_fr": "Shampoing",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150642,
    "drug": {
      "current_status": "MARKETED",
      "id": 100344,
      "drug_code": 98733,
      "updated_date": "2020-04-03T06:54:38-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264932,
          "ingredient": {
            "id": 1660,
            "ingredient_code": 2442,
            "en_name": "CLOMIPRAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de clomipramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02497514",
      "brand_name": "TARO-CLOMIPRAMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109212002"
    },
    "created_date": "2021-12-07T19:24:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02497514",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-01-21T00:00:00-05:00",
    "actual_start_date": "2021-11-25T00:00:00-05:00",
    "actual_end_date": "2021-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-06T20:43:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOMIPRAMINE",
    "en_drug_common_name": "CLOMIPRAMINE",
    "fr_drug_brand_name": "TARO-CLOMIPRAMINE",
    "fr_drug_common_name": "CLOMIPRAMINE",
    "en_ingredients": "CLOMIPRAMINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de clomipramine",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150659,
    "drug": {
      "current_status": "MARKETED",
      "id": 17848,
      "drug_code": 78903,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256263,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303736",
      "brand_name": "TARO-CIPROFLOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207001"
    },
    "created_date": "2021-12-07T20:21:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303736",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2022-02-25T00:00:00-05:00",
    "actual_start_date": "2021-11-02T00:00:00-04:00",
    "actual_end_date": "2022-06-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-19T15:41:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CIPROFLOX",
    "en_drug_common_name": "CIPROFLOX",
    "fr_drug_brand_name": "TARO-CIPROFLOX",
    "fr_drug_common_name": "CIPROFLOX",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150662,
    "drug": {
      "current_status": "MARKETED",
      "id": 20082,
      "drug_code": 81483,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257079,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02329131",
      "brand_name": "TARO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415001"
    },
    "created_date": "2021-12-07T20:23:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329131",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-10-07T00:00:00-04:00",
    "actual_start_date": "2022-06-22T00:00:00-04:00",
    "actual_end_date": "2022-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-04T00:26:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "TARO-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150671,
    "drug": {
      "current_status": "DORMANT",
      "id": 16948,
      "drug_code": 77958,
      "updated_date": "2025-12-03T02:32:23-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368062,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02294230",
      "brand_name": "TARO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550003"
    },
    "created_date": "2021-12-07T20:35:34-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02294230",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2021-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-07T20:35:55-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "RAN-LISINOPRIL",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "TARO-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150674,
    "drug": {
      "current_status": "DORMANT",
      "id": 16954,
      "drug_code": 77960,
      "updated_date": "2025-12-03T02:32:23-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368064,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02294257",
      "brand_name": "TARO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550002"
    },
    "created_date": "2021-12-07T20:36:56-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02294257",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2021-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-07T20:37:12-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "RAN-LISINOPRIL",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "TARO-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150683,
    "drug": {
      "current_status": "MARKETED",
      "id": 100827,
      "drug_code": 97239,
      "updated_date": "2020-09-03T01:52:25-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263654,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        },
        {
          "id": 8263653,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02481901",
      "brand_name": "TARO-CIPROFLOXACIN/DEXAMETHASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250083001"
    },
    "created_date": "2021-12-07T20:48:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02481901",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "S02CA",
    "atc_description": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
    "estimated_end_date": "2024-09-27T00:00:00-04:00",
    "actual_start_date": "2022-07-26T00:00:00-04:00",
    "actual_end_date": "2024-09-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-27T18:32:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CIPROFLOXACIN/DEXAMETHASONE",
    "en_drug_common_name": "CIPRO/DEXA",
    "fr_drug_brand_name": "TARO-CIPROFLOXACIN/DEXAMETHASONE",
    "fr_drug_common_name": "CIPRO/DEXA",
    "en_ingredients": "DEXAMETHASONE\r\nCIPROFLOXACIN",
    "fr_ingredients": "Dexaméthasone\r\nCiprofloxacine",
    "drug_strength": "0.1%\r\n0.3%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OTIC",
    "drug_route_fr": "Otique",
    "drug_package_quantity": "7.5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150686,
    "drug": {
      "current_status": "MARKETED",
      "id": 5554,
      "drug_code": 36952,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252872,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02213265",
      "brand_name": "DERMOVATE CREAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4378",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2021-12-07T20:53:55-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02213265",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "discontinuation_date": "2021-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-07T20:54:15-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "DERMOVATE CREAM",
    "en_drug_common_name": "DERMOVATE",
    "fr_drug_brand_name": "TARO-DERMOVATE",
    "fr_drug_common_name": "DERMOVATE",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150693,
    "drug": {
      "current_status": "MARKETED",
      "id": 10740,
      "drug_code": 66475,
      "updated_date": "2025-05-15T02:31:11-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254065,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242685",
      "brand_name": "TARO-WARFARIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104597001"
    },
    "created_date": "2021-12-07T21:23:26-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242685",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2021-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-07T21:23:41-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "TARO-WARFARIN",
    "en_drug_common_name": "WARFARIN",
    "fr_drug_brand_name": "TARO-WARFARIN",
    "fr_drug_common_name": "WARFARIN",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "10 X 10",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150702,
    "drug": {
      "current_status": "MARKETED",
      "id": 902,
      "drug_code": 1215,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250244,
          "ingredient": {
            "id": 548,
            "ingredient_code": 11190,
            "en_name": "KETAMINE",
            "fr_name": "Kétamine (Chlorhydrate de kétamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00224405",
      "brand_name": "KETALAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "37466",
      "number_of_ais": "1",
      "ai_group_no": "0131360003"
    },
    "created_date": "2021-12-08T13:31:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00224405",
    "company_name": "ERFA CANADA 2012 INC",
    "atc_number": "N01AX",
    "atc_description": "ANESTHETICS, GENERAL",
    "anticipated_start_date": "2021-12-10T00:00:00-05:00",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-03-08T17:47:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "KETALAR",
    "en_drug_common_name": "KETALAR 50MG",
    "fr_drug_brand_name": "KETALAR",
    "fr_drug_common_name": "KETALAR 50MG",
    "en_ingredients": "KETAMINE",
    "fr_ingredients": "KETAMINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "VIAL 10ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150721,
    "drug": {
      "current_status": "MARKETED",
      "id": 27936,
      "drug_code": 90141,
      "updated_date": "2025-05-15T02:34:07-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8260149,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260148,
          "ingredient": {
            "id": 3440,
            "ingredient_code": 20179,
            "en_name": "SITAGLIPTIN",
            "fr_name": "Sitagliptine (Phosphate de sitagliptine monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416808",
      "brand_name": "JANUMET XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252656004"
    },
    "created_date": "2021-12-08T15:10:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416808",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2021-12-14T00:00:00-05:00",
    "estimated_end_date": "2021-12-20T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2021-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-15T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Expected shortage due to quality testing delay.",
    "fr_comments": "Pénurie attendue en raison du retard des tests de qualité",
    "en_drug_brand_name": "JANUMET XR",
    "en_drug_common_name": "sitagliptin and metformin hydrochloride modified-release tablets",
    "fr_drug_brand_name": "JANUMET XR",
    "fr_drug_common_name": "\"comprimés à libération modifiée de sitagliptine et de chlorhydrate de metformine\"",
    "en_ingredients": "METFORMIN HYDROCHLORIDE\r\nSITAGLIPTIN",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "1000MG\r\n100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150725,
    "drug": {
      "current_status": "MARKETED",
      "id": 18994,
      "drug_code": 80257,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256648,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317060",
      "brand_name": "PMS-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2021-12-08T16:07:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317060",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2023-06-12T00:00:00-04:00",
    "actual_start_date": "2023-05-01T00:00:00-04:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T15:40:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "pms-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150727,
    "drug": {
      "current_status": "MARKETED",
      "id": 65343,
      "drug_code": 81499,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 12493,
        "created_date": "2019-06-14T02:15:03-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 17542,
        "mfr_code": "",
        "name": "CURIUM CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "217 & 220",
        "street_name": "2572 BOUL. DANIEL-JOHNSON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2R3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257089,
          "ingredient": {
            "id": 29109,
            "ingredient_code": 20494,
            "en_name": "BETIATIDE",
            "fr_name": "Bétiatide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02329298",
      "brand_name": "TECHNESCAN MAG3",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0160990001"
    },
    "created_date": "2021-12-08T16:14:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329298",
    "company_name": "CURIUM CANADA INC",
    "atc_number": "V09CA",
    "estimated_end_date": "2021-12-19T00:00:00-05:00",
    "actual_start_date": "2021-12-08T00:00:00-05:00",
    "actual_end_date": "2021-12-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-01-20T20:43:34-05:00",
    "status": "resolved",
    "en_comments": "We have currently depleted inventory on Technescan MAG3 (kit for the preparation of technetium Tc 99m mertiatide), 5 vial packs – product item code 096B0CA. The next lot is expected to release by December 17, 2021 and shipped to Canada by December 19.\r\nWe understand the inconvenience this may cause you and apologize for the disruption.",
    "fr_comments": "Nous avons actuellement épuisé nos stocks de Technescan MAG3 (kit pour la préparation de technétium Tc 99m mertiatide), 5 packs de flacons - code article 096B0CA. Le prochain lot devrait être relâché d'ici le 17 décembre 2021 et être expédié au Canada d'ici le 19 décembre.\r\nNous comprenons les inconvénients que cela peut vous causer et nous nous excusons pour la perturbation.",
    "en_drug_brand_name": "TECHNESCAN MAG3",
    "en_drug_common_name": "Kit for the Preparation of Technetium  Tc 99m Mertiatide",
    "fr_drug_brand_name": "Technescan MAG3",
    "fr_drug_common_name": "Trousse pour la préparation du Mertiatide marqué au Technetium Tc 99m",
    "en_ingredients": "BETIATIDE",
    "fr_ingredients": "betiatide",
    "drug_strength": "1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ml vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150734,
    "drug": {
      "current_status": "MARKETED",
      "id": 27934,
      "drug_code": 90140,
      "updated_date": "2025-05-15T02:34:07-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8260147,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260146,
          "ingredient": {
            "id": 3440,
            "ingredient_code": 20179,
            "en_name": "SITAGLIPTIN",
            "fr_name": "Sitagliptine (Phosphate de sitagliptine monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416794",
      "brand_name": "JANUMET XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252656003"
    },
    "created_date": "2021-12-08T16:48:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416794",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2021-12-13T00:00:00-05:00",
    "actual_start_date": "2021-12-07T00:00:00-05:00",
    "actual_end_date": "2021-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-14T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Shortage due to quality testing delay",
    "fr_comments": "Pénurie due au retard des tests de qualité",
    "en_drug_brand_name": "JANUMET XR",
    "en_drug_common_name": "sitagliptin and metformin hydrochloride modified-release tablets",
    "fr_drug_brand_name": "JANUMET XR",
    "fr_drug_common_name": "\"comprimés à libération modifiée de sitagliptine et de chlorhydrate de metformine\"",
    "en_ingredients": "METFORMIN HYDROCHLORIDE\r\nSITAGLIPTIN",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "1000MG\r\n50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150737,
    "drug": {
      "current_status": "MARKETED",
      "id": 3124,
      "drug_code": 18005,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252237,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02132702",
      "brand_name": "ZOLOFT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80217",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2021-12-08T16:54:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02132702",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2021-12-15T00:00:00-05:00",
    "estimated_end_date": "2022-02-18T00:00:00-05:00",
    "actual_end_date": "2022-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-18T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOLOFT",
    "en_drug_common_name": "Zoloft",
    "fr_drug_brand_name": "ZOLOFT",
    "fr_drug_common_name": "Zoloft",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "BTL 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150740,
    "drug": {
      "current_status": "MARKETED",
      "id": 26864,
      "drug_code": 8915,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251111,
          "ingredient": {
            "id": 2106,
            "ingredient_code": 1305,
            "en_name": "NIZATIDINE",
            "fr_name": "Nizatidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00778338",
      "brand_name": "AXID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67611",
      "number_of_ais": "1",
      "ai_group_no": "0120317001"
    },
    "created_date": "2021-12-08T16:55:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00778338",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-12-22T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2021-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-07T15:19:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AXID",
    "en_drug_common_name": "Axid (Nizatidine)",
    "fr_drug_brand_name": "AXID",
    "fr_drug_common_name": "Axid (Nizatidine)",
    "en_ingredients": "NIZATIDINE",
    "fr_ingredients": "Nizatidine",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 CAPS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150760,
    "drug": {
      "current_status": "MARKETED",
      "id": 54636,
      "drug_code": 95931,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262891,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470330",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548017"
    },
    "created_date": "2021-12-08T17:34:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470330",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2021-12-08T00:00:00-05:00",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-12-08T00:00:00-05:00",
    "actual_end_date": "2021-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-21T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "70MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150771,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13684,
      "drug_code": 73528,
      "updated_date": "2025-05-15T04:08:23-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8339759,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250489",
      "brand_name": "LEVITRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003003"
    },
    "created_date": "2021-12-08T19:56:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250489",
    "company_name": "BAYER INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2022-01-03T00:00:00-05:00",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2022-01-04T00:00:00-05:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-01T20:00:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVITRA",
    "en_drug_common_name": "Vardenafil",
    "fr_drug_brand_name": "Levitra",
    "fr_drug_common_name": "Vardenafil",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "Vardenafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150776,
    "drug": {
      "current_status": "MARKETED",
      "id": 11502,
      "drug_code": 68258,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254279,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02244291",
      "brand_name": "FLOVENT HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685001"
    },
    "created_date": "2021-12-08T20:22:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244291",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-03T00:00:00-05:00",
    "actual_end_date": "2022-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-05T20:33:19-05:00",
    "status": "resolved",
    "en_comments": "Limited supply on allocation. For emergency supply, contact GSK Customer Service at cacsu@gsk.com",
    "fr_comments": "Approvisionnement limité, sera alloué selon les besoins. Pour un approvisionnement d’urgence, communiquez avec le Service à la clientèle de GSK au cacsu@gsk.com",
    "en_drug_brand_name": "FLOVENT HFA",
    "en_drug_common_name": "fluticasone propionate inhalation aerosol",
    "fr_drug_brand_name": "FLOVENT HFA",
    "fr_drug_common_name": "propionate de fluticasone en aérosol pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "ORAL\r\nINHALATION\r\nORAL\r\nINHALATION",
    "drug_route_fr": "Orale\r\nInhalation\r\nOrale\r\nInhalation",
    "drug_package_quantity": "1x120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150839,
    "drug": {
      "current_status": "MARKETED",
      "id": 53455,
      "drug_code": 94808,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262286,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02460653",
      "brand_name": "APO-METFORMIN ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773003"
    },
    "created_date": "2021-12-09T14:31:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460653",
    "company_name": "APOTEX INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2022-02-11T00:00:00-05:00",
    "actual_start_date": "2021-12-07T00:00:00-05:00",
    "actual_end_date": "2022-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-24T13:36:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METFORMIN ER",
    "en_drug_common_name": "METFORMIN ER",
    "fr_drug_brand_name": "APO-METFORMIN ER",
    "fr_drug_common_name": "METFORMIN ER",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150853,
    "drug": {
      "current_status": "MARKETED",
      "id": 4962,
      "drug_code": 28440,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252770,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02089602",
      "brand_name": "PROPADERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "F4706",
      "number_of_ais": "1",
      "ai_group_no": "0106320001"
    },
    "created_date": "2021-12-09T14:39:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02089602",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "actual_start_date": "2021-11-22T00:00:00-05:00",
    "actual_end_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-02-10T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PROPADERM",
    "en_drug_common_name": "PROPADERM",
    "fr_drug_brand_name": "PROPADERM",
    "fr_drug_common_name": "PROPADERM",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "0.025%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "45g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150862,
    "drug": {
      "current_status": "MARKETED",
      "id": 10444,
      "drug_code": 65700,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253941,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02242029",
      "brand_name": "QVAR",
      "brand_name_fr": "",
      "descriptor": "SOLUTION FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106320002"
    },
    "created_date": "2021-12-09T14:42:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242029",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-04-27T00:00:00-04:00",
    "actual_start_date": "2021-11-25T00:00:00-05:00",
    "actual_end_date": "2022-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-28T13:47:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QVAR",
    "en_drug_common_name": "QVAR",
    "fr_drug_brand_name": "QVAR",
    "fr_drug_common_name": "QVAR",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "200 dose",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150882,
    "drug": {
      "current_status": "MARKETED",
      "id": 31292,
      "drug_code": 9351,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251152,
          "ingredient": {
            "id": 1928,
            "ingredient_code": 7247,
            "en_name": "SODIUM SULFATE",
            "fr_name": "Sulfate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "22.96",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BOTTLE",
          "base": false
        },
        {
          "id": 8251151,
          "ingredient": {
            "id": 2014,
            "ingredient_code": 13418,
            "en_name": "MACROGOL",
            "fr_name": "Macrogol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "238.18",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BOTTLE",
          "base": false
        },
        {
          "id": 8251150,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.05",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BOTTLE",
          "base": false
        },
        {
          "id": 8251149,
          "ingredient": {
            "id": 800,
            "ingredient_code": 9197,
            "en_name": "SODIUM BICARBONATE",
            "fr_name": "Bicarbonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.76",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BOTTLE",
          "base": false
        },
        {
          "id": 8251148,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.85",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BOTTLE",
          "base": false
        }
      ],
      "din": "00777838",
      "brand_name": "PEGLYTE POWDER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68360",
      "number_of_ais": "5",
      "ai_group_no": "0516978006"
    },
    "created_date": "2021-12-09T22:35:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00777838",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "A06AD",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2022-01-15T00:00:00-05:00",
    "actual_start_date": "2021-12-07T00:00:00-05:00",
    "actual_end_date": "2022-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-14T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PEGLYTE POWDER",
    "en_drug_common_name": "PEGLYTE POWDER",
    "fr_drug_brand_name": "PEGLYTE POUDRE",
    "fr_drug_common_name": "PEGLYTE POUDRE",
    "en_ingredients": "POTASSIUM CHLORIDE\r\nSODIUM CHLORIDE\r\nSODIUM BICARBONATE\r\nSODIUM SULFATE\r\nMACROGOL",
    "fr_ingredients": "Chlorure de potassium\r\nChlorure de sodium\r\nBicarbonate de sodium\r\nSulfate de sodium\r\nMacrogol",
    "drug_strength": "3.05G\r\n5.85G\r\n6.76G\r\n22.96G\r\n238.18G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4x70g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150885,
    "drug": {
      "current_status": "MARKETED",
      "id": 8574,
      "drug_code": 60166,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8253474,
          "ingredient": {
            "id": 2534,
            "ingredient_code": 11710,
            "en_name": "BRIMONIDINE TARTRATE",
            "fr_name": "Tartrate de brimonidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02236876",
      "brand_name": "ALPHAGAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131859001"
    },
    "created_date": "2021-12-10T01:20:50-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02236876",
    "company_name": "ALLERGAN INC",
    "atc_number": "S01EA",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_discontinuation_date": "2022-06-01T00:00:00-04:00",
    "decision_reversal": true,
    "fr_supply_disruption_mitigation": "5ml est Disponible",
    "en_discontinuation_comments": "5mL package size available",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-12-14T16:45:54-05:00",
    "status": "reversed",
    "en_drug_brand_name": "ALPHAGAN",
    "en_drug_common_name": "ALPHAGAN 0.2% Ophthalmic Solution brimonidine tartrate",
    "fr_drug_brand_name": "ALPHAGAN® (tartrate de brimonidine)",
    "fr_drug_common_name": "tartrate de brimonidine",
    "en_ingredients": "BRIMONIDINE TARTRATE",
    "fr_ingredients": "Tartrate de brimonidine",
    "drug_strength": "0.2%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150889,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3838,
      "drug_code": 1936,
      "updated_date": "2025-05-15T03:24:53-04:00",
      "company": {
        "id": 30,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 3574,
        "mfr_code": "ALL07",
        "name": "ALLERGAN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "300",
        "street_name": "1380 RODICK ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 4G5",
        "post_office_box": "",
        "contact_information": "Company contact information;\r\nTelephone number: 800-668-6424\r\nEmail address: MR-GENERAL_INQUIRY@allergan.com\r\nWebsite address: allergan.ca\r\nPostal address:  500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5"
      },
      "drug_ingredients": [
        {
          "id": 8272695,
          "ingredient": {
            "id": 70,
            "ingredient_code": 7617,
            "en_name": "PREDNISOLONE ACETATE",
            "fr_name": "Acétate de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.12",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00299405",
      "brand_name": "PRED MILD",
      "brand_name_fr": "",
      "descriptor": "SUSPENSION",
      "pediatric_flag": false,
      "accession_number": "45778",
      "number_of_ais": "1",
      "ai_group_no": "0106295002"
    },
    "created_date": "2021-12-10T01:33:56-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00299405",
    "company_name": "ALLERGAN INC",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "discontinuation_date": "2022-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-01T21:15:30-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRED MILD",
    "en_drug_common_name": "PRED MILD 0.12% Ophthalmic  Solution prednisolone acetate",
    "fr_drug_brand_name": "PRED MILD sol. oph. à 0,12 % acétate de prednisolone",
    "fr_drug_common_name": "acétate de prednisolone",
    "en_ingredients": "PREDNISOLONE ACETATE",
    "fr_ingredients": "Acétate de prednisolone",
    "drug_strength": "0.12%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ml",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150896,
    "drug": {
      "current_status": "MARKETED",
      "id": 101665,
      "drug_code": 99687,
      "updated_date": "2021-04-08T05:03:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8265766,
          "ingredient": {
            "id": 3590,
            "ingredient_code": 20524,
            "en_name": "SAXAGLIPTIN",
            "fr_name": "Saxagliptine (Chlorhydrate de saxagliptine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02507498",
      "brand_name": "APO-SAXAGLIPTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152653001"
    },
    "created_date": "2021-12-10T14:02:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02507498",
    "company_name": "APOTEX INC",
    "atc_number": "A10BH",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2022-02-09T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2022-01-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-31T13:27:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SAXAGLIPTIN",
    "en_drug_common_name": "SAXAGLIPTIN",
    "fr_drug_brand_name": "APO-SAXAGLIPTIN",
    "fr_drug_common_name": "SAXAGLIPTIN",
    "en_ingredients": "SAXAGLIPTIN",
    "fr_ingredients": "SAXAGLIPTIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150899,
    "drug": {
      "current_status": "MARKETED",
      "id": 13136,
      "drug_code": 72539,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254780,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02248203",
      "brand_name": "APO-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261003"
    },
    "created_date": "2021-12-10T14:08:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248203",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2021-12-22T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2021-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-22T18:13:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "APO-SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150910,
    "drug": {
      "current_status": "MARKETED",
      "id": 13134,
      "drug_code": 72538,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254779,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02248202",
      "brand_name": "APO-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261002"
    },
    "created_date": "2021-12-10T14:31:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248202",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2021-12-20T00:00:00-05:00",
    "actual_start_date": "2021-12-06T00:00:00-05:00",
    "actual_end_date": "2021-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-22T18:12:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "APO-SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150913,
    "drug": {
      "current_status": "DORMANT",
      "id": 101477,
      "drug_code": 100026,
      "updated_date": "2021-02-08T05:57:12-05:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369792,
          "ingredient": {
            "id": 3428,
            "ingredient_code": 20163,
            "en_name": "PALIPERIDONE",
            "fr_name": "Palipéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02511010",
      "brand_name": "MAR-PALIPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152320001"
    },
    "created_date": "2021-12-10T14:36:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02511010",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "hc_updated_date": "2023-07-13T15:21:20-04:00",
    "anticipated_start_date": "2021-11-11T00:00:00-05:00",
    "estimated_end_date": "2022-08-31T00:00:00-04:00",
    "actual_start_date": "2021-11-11T00:00:00-05:00",
    "actual_end_date": "2021-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-13T15:21:21-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MAR-PALIPERIDONE",
    "en_drug_common_name": "MAR-Paliperidone",
    "fr_drug_brand_name": "MAR-Paliperidone",
    "fr_drug_common_name": "MAR-Paliperidone",
    "en_ingredients": "PALIPERIDONE",
    "fr_ingredients": "Palipéridone",
    "drug_strength": "3MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottle x 100 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150916,
    "drug": {
      "current_status": "DORMANT",
      "id": 101478,
      "drug_code": 100027,
      "updated_date": "2021-02-08T05:57:12-05:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369793,
          "ingredient": {
            "id": 3428,
            "ingredient_code": 20163,
            "en_name": "PALIPERIDONE",
            "fr_name": "Palipéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02511029",
      "brand_name": "MAR-PALIPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152320002"
    },
    "created_date": "2021-12-10T14:39:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02511029",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "hc_updated_date": "2023-07-13T15:22:05-04:00",
    "anticipated_start_date": "2021-11-11T00:00:00-05:00",
    "estimated_end_date": "2022-08-31T00:00:00-04:00",
    "actual_start_date": "2021-11-11T00:00:00-05:00",
    "actual_end_date": "2022-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-13T15:22:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-PALIPERIDONE",
    "en_drug_common_name": "MAR-Paliperidone",
    "fr_drug_brand_name": "MAR-Paliperidone",
    "fr_drug_common_name": "MAR-Paliperidone",
    "en_ingredients": "PALIPERIDONE",
    "fr_ingredients": "Palipéridone",
    "drug_strength": "6MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottle x 100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150921,
    "drug": {
      "current_status": "MARKETED",
      "id": 11756,
      "drug_code": 69137,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254365,
          "ingredient": {
            "id": 2000,
            "ingredient_code": 11282,
            "en_name": "SALMETEROL",
            "fr_name": "Salmétérol (Xinafoate de salmétérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8254364,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02245127",
      "brand_name": "ADVAIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0238341006"
    },
    "created_date": "2021-12-10T15:56:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245127",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2022-01-04T00:00:00-05:00",
    "actual_start_date": "2021-12-07T00:00:00-05:00",
    "actual_end_date": "2022-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-05T19:49:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ADVAIR 250",
    "en_drug_common_name": "fluticasone propionate and salmeterol pressurized inhalation, suspension",
    "fr_drug_brand_name": "ADVAIR 250",
    "fr_drug_common_name": "propionate de fluticasone et salmétérol en suspension pressurisée pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE\r\nSALMETEROL",
    "fr_ingredients": "Propionate de fluticasone; Salmétérol (Xinafoate de salmétérol)",
    "drug_strength": "250MCG\r\n25MCG",
    "drug_dosage_form": "AEROSOL, METERED DOSE",
    "drug_dosage_form_fr": "Aérosol, dose mesurée",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150924,
    "drug": {
      "current_status": "MARKETED",
      "id": 6262,
      "drug_code": 43089,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253029,
          "ingredient": {
            "id": 2134,
            "ingredient_code": 11118,
            "en_name": "CEFUROXIME",
            "fr_name": "Céfuroxime (Céfuroxime sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02212307",
      "brand_name": "CEFTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9381",
      "number_of_ais": "1",
      "ai_group_no": "0122448005"
    },
    "created_date": "2021-12-10T16:06:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212307",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-01-26T00:00:00-05:00",
    "actual_start_date": "2021-12-07T00:00:00-05:00",
    "actual_end_date": "2022-01-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-26T16:48:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTIN",
    "en_drug_common_name": "cefuroxime axetil for oral suspension",
    "fr_drug_brand_name": "CEFTIN",
    "fr_drug_common_name": "céfuroxime axétil pour suspension orale",
    "en_ingredients": "CEFUROXIME",
    "fr_ingredients": "Céfuroxime (Céfuroxime axétil)",
    "drug_strength": "125MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150927,
    "drug": {
      "current_status": "MARKETED",
      "id": 8698,
      "drug_code": 60566,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253508,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02237246",
      "brand_name": "FLOVENT DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685003"
    },
    "created_date": "2021-12-10T16:12:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237246",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-01-04T00:00:00-05:00",
    "actual_start_date": "2021-12-08T00:00:00-05:00",
    "actual_end_date": "2022-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-05T20:34:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FLOVENT DISKUS",
    "en_drug_common_name": "fluticasone propionate powder for inhalation",
    "fr_drug_brand_name": "FLOVENT DISKUS",
    "fr_drug_common_name": "propionate de fluticasone en poudre pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "250MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150930,
    "drug": {
      "current_status": "MARKETED",
      "id": 7292,
      "drug_code": 49288,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253267,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230418",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238003"
    },
    "created_date": "2021-12-10T16:25:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230418",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-01-27T00:00:00-05:00",
    "actual_start_date": "2021-12-07T00:00:00-05:00",
    "actual_end_date": "2022-01-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-26T16:50:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX NASAL SPRAY",
    "en_drug_common_name": "Sumatriptan nasal spray",
    "fr_drug_brand_name": "IMITREX NASAL SPRAY",
    "fr_drug_common_name": "Vaporisation nasale de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan",
    "drug_strength": "5MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "2s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150933,
    "drug": {
      "current_status": "MARKETED",
      "id": 4740,
      "drug_code": 2527,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250423,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "149",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037869",
      "brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50067",
      "number_of_ais": "1",
      "ai_group_no": "0100273006"
    },
    "created_date": "2021-12-10T17:24:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037869",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2021-12-10T00:00:00-05:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP",
    "en_drug_common_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP",
    "fr_drug_brand_name": "Chlorure de potassium pour injection",
    "fr_drug_common_name": "Chlorure de potassium pour injection",
    "en_ingredients": "POTASSIUM CHLORIDE",
    "fr_ingredients": "Chlorure de potassium",
    "drug_strength": "149MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25 x 20mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150947,
    "drug": {
      "current_status": "MARKETED",
      "id": 25294,
      "drug_code": 87773,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259168,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02392453",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE. 0.5ML SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596002"
    },
    "created_date": "2021-12-10T19:58:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392453",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2021-12-15T00:00:00-05:00",
    "estimated_end_date": "2022-01-10T00:00:00-05:00",
    "actual_end_date": "2022-01-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-17T19:14:17-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to further shipping delays we will be extending the backorder on our Heparin Sodium Injection, USP 10 000 USP units/mL SD Vial 0.5 mL until January 10, 2022. Our Heparin Sodium Injection, USP 10 000 USP units/mL MD Vial 1 mL format will be available for substitution.",
    "fr_comments": "Au nom de Fresenius Kabi Canada Ltée, j’ai le regret de vous aviser qu’en raison d’autres retards d’expédition, nous allons éprouver une prolongation de la rupture de stock touchant notre préparation d’Héparine sodique injectable, USP à 10 000 unités USP/mL en fioles DU de 0,5 mL jusqu’au 10 janvier 2022. Notre préparation d’Héparine sodique injectable, USP à 10 000 unités USP/mL en fioles DM de 1 mL sera disponible en guise de substitut",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "Heparin Sodium Injection, USP 10 000 USP units/mL SD Vial 0.5 mL",
    "fr_drug_brand_name": "Héparine sodique injectable, USP",
    "fr_drug_common_name": "Héparine sodique injectable, USP à 10 000 unités USP/mL, en fioles DU, 0,5 mL",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "0.5 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150950,
    "drug": {
      "current_status": "MARKETED",
      "id": 630,
      "drug_code": 11372,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251520,
          "ingredient": {
            "id": 418,
            "ingredient_code": 8344,
            "en_name": "CEFTAZIDIME",
            "fr_name": "Ceftazidime (Ceftazidime pentahydratée)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00886955",
      "brand_name": "CEFTAZIDIME FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72034",
      "number_of_ais": "1",
      "ai_group_no": "0116900002"
    },
    "created_date": "2021-12-10T20:00:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00886955",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "anticipated_start_date": "2021-12-29T00:00:00-05:00",
    "estimated_end_date": "2022-06-01T00:00:00-04:00",
    "actual_end_date": "2022-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-24T15:50:53-04:00",
    "status": "resolved",
    "en_comments": "Sterimax is an alternate supplier of Ceftazidime for Injection and have been informed of our impending supply interruption.",
    "fr_comments": "Sterimax étant un autre fournisseur de Ceftazidime pour injection, nous l’avons informé de notre situation imminente d’interruption d’approvisionnement.",
    "en_drug_brand_name": "CEFTAZIDIME FOR INJECTION, USP",
    "en_drug_common_name": "Ceftazidime for Injection, USP 2 g SD Vial 50 mL",
    "fr_drug_brand_name": "Ceftazidime pour injection, USP",
    "fr_drug_common_name": "Ceftazidime pour injection, USP 2 g, fioles DU, 50 mL",
    "en_ingredients": "CEFTAZIDIME",
    "fr_ingredients": "Ceftazidime",
    "drug_strength": "2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150953,
    "drug": {
      "current_status": "MARKETED",
      "id": 26524,
      "drug_code": 88832,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259575,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02403536",
      "brand_name": "5% DEXTROSE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2021-12-10T20:01:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403536",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-12-10T00:00:00-05:00",
    "estimated_end_date": "2021-12-17T00:00:00-05:00",
    "actual_start_date": "2021-12-10T00:00:00-05:00",
    "actual_end_date": "2021-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-17T20:49:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXTROSE 5% INJECTION",
    "en_drug_common_name": "Dextrose 5% Injection freeflex® Bag 50 mL",
    "fr_drug_brand_name": "Dextrose injectable, 5 %, sacs freeflexMD, 50 mL",
    "fr_drug_common_name": "Dextrose injectable, 5 %, sacs freeflexMD, 50 mL",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150956,
    "drug": {
      "current_status": "MARKETED",
      "id": 26524,
      "drug_code": 88832,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259575,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02403536",
      "brand_name": "5% DEXTROSE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2021-12-10T20:03:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403536",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2021-12-10T00:00:00-05:00",
    "estimated_end_date": "2022-01-24T00:00:00-05:00",
    "actual_start_date": "2021-12-10T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-20T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Our Dextrose 5% Injection freeflex® Bag 250 mL format is available for substitution for the 100 mL",
    "fr_comments": "Notre préparation de Dextrose injectable à 5 % en sacs freeflexMD de 250 mL est disponible en guise de substitut pour le format de 100 mL",
    "en_drug_brand_name": "DEXTROSE 5% INJECTION",
    "en_drug_common_name": "Dextrose 5% Injection freeflex® Bag 100 mL",
    "fr_drug_brand_name": "Dextrose injectable, 5 %, sacs freeflexMD, 100 mL",
    "fr_drug_common_name": "Dextrose injectable, 5 %, sacs freeflexMD, 100 mL",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150995,
    "drug": {
      "current_status": "MARKETED",
      "id": 57611,
      "drug_code": 81516,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 10230,
        "created_date": "2018-10-02T03:00:06-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 14691,
        "mfr_code": "",
        "name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16751 TRANS CANADA HWY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4J4",
        "post_office_box": "",
        "contact_information": "Hiba Soulaihi \r\nHSoulaihi@jubl.com"
      },
      "drug_ingredients": [
        {
          "id": 8257092,
          "ingredient": {
            "id": 4200,
            "ingredient_code": 3275,
            "en_name": "ALBUMIN",
            "fr_name": "Albumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02329417",
      "brand_name": "DRAXIMAGE MAA",
      "brand_name_fr": "",
      "descriptor": "KIT FOR THE PREPARATION OF TECHNETIUM TC 99M ALBUMIN AGGREGATED INJECTION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106239004"
    },
    "created_date": "2021-12-13T16:21:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329417",
    "company_name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
    "atc_number": "B05AA",
    "atc_description": "BLOOD AND RELATED PRODUCTS",
    "estimated_end_date": "2021-12-29T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2021-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-29T18:27:33-05:00",
    "status": "resolved",
    "en_comments": "Delay in product release.",
    "fr_comments": "Retard dans la relâche  du produit.",
    "en_drug_brand_name": "DRAXIMAGE MAA",
    "en_drug_common_name": "Kit for the Preparation of Technetium Tc 99m Albumin Aggregated Injection",
    "fr_drug_brand_name": "DRAXIMAGE MAA",
    "fr_drug_common_name": "Trousse pour la préparation d’agrégats d’albumine injectable marqués au technétium Tc 99m",
    "en_ingredients": "ALBUMIN",
    "fr_ingredients": "Albumine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 Vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 150999,
    "drug": {
      "current_status": "MARKETED",
      "id": 57603,
      "drug_code": 81314,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10230,
        "created_date": "2018-10-02T03:00:06-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 14691,
        "mfr_code": "",
        "name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16751 TRANS CANADA HWY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4J4",
        "post_office_box": "",
        "contact_information": "Hiba Soulaihi \r\nHSoulaihi@jubl.com"
      },
      "drug_ingredients": [
        {
          "id": 8257032,
          "ingredient": {
            "id": 13857,
            "ingredient_code": 12391,
            "en_name": "TETRAKIS [CU",
            "fr_name": "TETRAKIS [CU(MIBI)4]BF4"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02327732",
      "brand_name": "DRAXIMAGE SESTAMIBI",
      "brand_name_fr": "",
      "descriptor": "KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152590001"
    },
    "created_date": "2021-12-13T16:32:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327732",
    "company_name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
    "atc_number": "V09GA",
    "estimated_end_date": "2021-12-13T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2021-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-14T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Delay in product release. \r\nThe product will become available by end of the day  December 13, 2021.",
    "fr_comments": "Retard dans la relâche  du produit. \r\nLe produit sera disponible d'ici la fin de la journée le 13 decembre 2021.",
    "en_drug_brand_name": "DRAXIMAGE SESTAMIBI",
    "en_drug_common_name": "Kit for the Preparation of Technetium Tc 99m Sestamibi Injection",
    "fr_drug_brand_name": "DRAXIMAGE Sestamibi",
    "fr_drug_common_name": "Trousse pour la préparation du sestamibi injectable marqué au technétium Tc 99m",
    "en_ingredients": "TETRAKIS [CU",
    "fr_ingredients": "Tetrakis [CU]",
    "drug_strength": "1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 Vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151037,
    "drug": {
      "current_status": "MARKETED",
      "id": 8946,
      "drug_code": 613,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250165,
          "ingredient": {
            "id": 252,
            "ingredient_code": 10209,
            "en_name": "PHENYTOIN",
            "fr_name": "Phénytoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00023450",
      "brand_name": "DILANTIN-125 SUSPENSION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "25032",
      "number_of_ais": "1",
      "ai_group_no": "0101372001"
    },
    "created_date": "2021-12-13T20:59:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00023450",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "N03AB",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2021-12-23T00:00:00-05:00",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_start_date": "2022-01-07T00:00:00-05:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "One lot with an expiry date of June/30/2022 remains available in stock",
    "fr_comments": "Un lot avec la date d'expiration du 30/Juin/2022 demeure disponible en inventaire",
    "en_drug_brand_name": "DILANTIN-125 SUSPENSION",
    "en_drug_common_name": "Dilantin",
    "fr_drug_brand_name": "DILANTIN",
    "fr_drug_common_name": "Dilantin",
    "en_ingredients": "PHENYTOIN",
    "fr_ingredients": "Phénytoïne",
    "drug_strength": "125MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Oral Suspension 250ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151039,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6492,
      "drug_code": 43416,
      "updated_date": "2025-05-15T03:49:53-04:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8312970,
          "ingredient": {
            "id": 2186,
            "ingredient_code": 11250,
            "en_name": "BUSERELIN",
            "fr_name": "Buséréline (Acétate de buséréline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02225158",
      "brand_name": "SUPREFACT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9754",
      "number_of_ais": "1",
      "ai_group_no": "0117891004"
    },
    "created_date": "2021-12-13T21:02:18-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02225158",
    "company_name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
    "atc_number": "L02AE",
    "atc_description": "HORMONES AND RELATED AGENTS",
    "discontinuation_date": "2021-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2021-12-13T21:03:10-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SUPREFACT",
    "en_drug_common_name": "Buserelin",
    "fr_drug_brand_name": "Suprefact",
    "fr_drug_common_name": "Buserelin",
    "en_ingredients": "BUSERELIN",
    "fr_ingredients": "Buserelin",
    "drug_strength": "100MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "10ml Spray",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151043,
    "drug": {
      "current_status": "MARKETED",
      "id": 32132,
      "drug_code": 9823,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251214,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00846503",
      "brand_name": "LOSEC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69128",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2021-12-13T21:16:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00846503",
    "company_name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_start_date": "2022-01-03T00:00:00-05:00",
    "actual_end_date": "2022-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-25T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSEC",
    "en_drug_common_name": "Omeprazole",
    "fr_drug_brand_name": "Losec Capsules",
    "fr_drug_common_name": "Omeprazole",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottle of 30 Capsules",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151046,
    "drug": {
      "current_status": "MARKETED",
      "id": 6494,
      "drug_code": 43417,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253078,
          "ingredient": {
            "id": 2186,
            "ingredient_code": 11250,
            "en_name": "BUSERELIN",
            "fr_name": "Buséréline (Acétate de buséréline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02225166",
      "brand_name": "SUPREFACT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9755",
      "number_of_ais": "1",
      "ai_group_no": "0117891001"
    },
    "created_date": "2021-12-13T21:21:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02225166",
    "company_name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
    "atc_number": "L02AE",
    "atc_description": "HORMONES AND RELATED AGENTS",
    "anticipated_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2021-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-02-16T01:37:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SUPREFACT",
    "en_drug_common_name": "Buserelin",
    "fr_drug_brand_name": "SUPREFACT",
    "fr_drug_common_name": "Buserelin",
    "en_ingredients": "BUSERELIN",
    "fr_ingredients": "Buserelin",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "2x5.5 mL Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151063,
    "drug": {
      "current_status": "MARKETED",
      "id": 56380,
      "drug_code": 95926,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262886,
          "ingredient": {
            "id": 116,
            "ingredient_code": 9880,
            "en_name": "METRONIDAZOLE",
            "fr_name": "Métronidazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470284",
      "brand_name": "AURO-METRONIDAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102572003"
    },
    "created_date": "2021-12-13T21:47:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470284",
    "company_name": "AURO PHARMA INC",
    "atc_number": "P01AB",
    "atc_description": "AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.",
    "estimated_end_date": "2022-02-15T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-15T18:23:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-METRONIDAZOLE",
    "en_drug_common_name": "Metronidazole",
    "fr_drug_brand_name": "AURO-METRONIDAZOLE",
    "fr_drug_common_name": "Metronidazole",
    "en_ingredients": "METRONIDAZOLE",
    "fr_ingredients": "Métronidazole",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151068,
    "drug": {
      "current_status": "MARKETED",
      "id": 14778,
      "drug_code": 75141,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255307,
          "ingredient": {
            "id": 1566,
            "ingredient_code": 169,
            "en_name": "SEVOFLURANE",
            "fr_name": "Sévoflurane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "99.97",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02265974",
      "brand_name": "SEVOFLURANE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127780001"
    },
    "created_date": "2021-12-13T21:50:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02265974",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "N01AB",
    "atc_description": "ANESTHETICS, GENERAL",
    "anticipated_start_date": "2021-12-13T00:00:00-05:00",
    "estimated_end_date": "2022-01-19T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-01-20T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "For customers who have Sevoflurane vaporizers with a Draeger-fil or Safe-t-Seal filling port (refer to your device or current filling adaptor for reference), Sevoflurane with an integrated valve (code: CA2L9117SV DIN: 02265974) can be used as an alternative product. Request allocation release from Baxter Customer Care. \r\nSuprane (desflurane)  (Code: CA2L9102ALU DIN:02227428) is also available as an alternative if it aligns with clinical practice.",
    "fr_comments": "Pour les clients qui ont des évaporateurs sevoflurane avec un port de remplissage “Draeger-fil” ou “Safe-t-Seal\" (référez-vous à votre équipement ou vos adaptateurs de remplissage pour référence), Sevoflurane avec valve intégrée (item: CA2L9117SV DIN: 02265974) peut être utilisé comme produit de substitution. Veuillez demander la libération de l'allocation auprès du service à la clientèle de Baxter. Suprane (desflurane) (item: CA2L9102ALU DIN : 02227428) est disponible comme alternative s'il s'aligne avec votre pratique clinique.",
    "en_drug_brand_name": "SEVOFLURANE",
    "en_drug_common_name": "SEVOFLURANE",
    "fr_drug_brand_name": "SEVOFLURANE",
    "fr_drug_common_name": "SEVOFLURANE",
    "en_ingredients": "SEVOFLURANE",
    "fr_ingredients": "Sévoflurane",
    "drug_strength": "99.97%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "250mL bottle (CA2L9117)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151103,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8942,
      "drug_code": 6129,
      "updated_date": "2025-05-15T03:29:30-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8279858,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00596965",
      "brand_name": "STATEX SUPPOSITORIES 20MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62369",
      "number_of_ais": "1",
      "ai_group_no": "0104545002"
    },
    "created_date": "2021-12-14T16:07:10-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00596965",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2021-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "No more supply",
    "fr_supply_disruption_mitigation": "Aucun inventaire restant",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-15T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "STATEX SUPPOSITORIES 20MG",
    "en_drug_common_name": "STATEX",
    "fr_drug_brand_name": "STATEX",
    "fr_drug_common_name": "STATEX",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "20MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "10 Suppositories",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151106,
    "drug": {
      "current_status": "MARKETED",
      "id": 14266,
      "drug_code": 74343,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8255143,
          "ingredient": {
            "id": 2428,
            "ingredient_code": 11461,
            "en_name": "IRINOTECAN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'irinotécan (Chlorhydrate trihydraté d'irinotécan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02258218",
      "brand_name": "IRINOTECAN HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132910001"
    },
    "created_date": "2021-12-14T16:48:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258218",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01CE",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-07-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-05T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRINOTECAN HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "IRINOTECAN",
    "fr_drug_brand_name": "IRINOTECAN",
    "fr_drug_common_name": "IRINOTECAN",
    "en_ingredients": "IRINOTECAN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'irinotécan",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151109,
    "drug": {
      "current_status": "MARKETED",
      "id": 3612,
      "drug_code": 19050,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252412,
          "ingredient": {
            "id": 1516,
            "ingredient_code": 6750,
            "en_name": "CODEINE",
            "fr_name": "Codéine (Phosphate de codéine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02163748",
      "brand_name": "CODEINE CONTIN 100MG CONTROLLED RELEASE TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81339",
      "number_of_ais": "1",
      "ai_group_no": "0153086004"
    },
    "created_date": "2021-12-14T16:54:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02163748",
    "company_name": "PURDUE PHARMA",
    "atc_number": "R05DA",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "anticipated_start_date": "2021-12-13T00:00:00-05:00",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2021-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-22T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CODEINE CONTIN 100MG CONTROLLED RELEASE TAB",
    "en_drug_common_name": "Codeine Controlled Release Tablets",
    "fr_drug_brand_name": "CODEINE CONTIN",
    "fr_drug_common_name": "Comprimés de codéine à libération contrôlée",
    "en_ingredients": "CODEINE",
    "fr_ingredients": "Codéine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151112,
    "drug": {
      "current_status": "MARKETED",
      "id": 31400,
      "drug_code": 93692,
      "updated_date": "2025-12-03T00:33:00-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261685,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02450771",
      "brand_name": "BUTRANS 15",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241009"
    },
    "created_date": "2021-12-14T16:59:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450771",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AE",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-12-13T00:00:00-05:00",
    "estimated_end_date": "2022-02-18T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-02-05T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BUTRANS 15",
    "en_drug_common_name": "Buprenorphine Transdermal System",
    "fr_drug_brand_name": "BuTrans",
    "fr_drug_common_name": "Système transdermique de buprénorphine",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "15MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151115,
    "drug": {
      "current_status": "MARKETED",
      "id": 6724,
      "drug_code": 44185,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253159,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "518",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172739",
      "brand_name": "OMNIPAQUE 240",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9819",
      "number_of_ais": "1",
      "ai_group_no": "0116846003"
    },
    "created_date": "2021-12-14T17:38:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172739",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "estimated_end_date": "2021-12-16T00:00:00-05:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2021-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-12-17T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 240",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "Omnipaque 240",
    "fr_drug_common_name": "injection d'iohexol USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "518MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR\r\nSUBARACHNOIDAL\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL",
    "drug_route_fr": "Intravasculaire\r\nSous-arachnoÏdienne\r\nIntravasculaire\r\nSous-arachnoÏdienne",
    "drug_package_quantity": "200 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151119,
    "drug": {
      "current_status": "MARKETED",
      "id": 62394,
      "drug_code": 97437,
      "updated_date": "2025-05-15T02:37:16-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8263806,
          "ingredient": {
            "id": 18411,
            "ingredient_code": 20488,
            "en_name": "EXAMETAZIME",
            "fr_name": "Examétazime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02484048",
      "brand_name": "CERETEC",
      "brand_name_fr": "",
      "descriptor": "WITH COBALT STABILIZER SOLUTION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152612001"
    },
    "created_date": "2021-12-14T17:46:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02484048",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V09HA",
    "estimated_end_date": "2022-01-06T00:00:00-05:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2021-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-01T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CERETEC",
    "en_drug_common_name": "Kit for the Preparation of Technetium-99m Exametazime Injection",
    "fr_drug_brand_name": "Ceretec",
    "fr_drug_common_name": "Trousse pour la préparation d’injections d’examétazime au technétium Tc99m",
    "en_ingredients": "EXAMETAZIME",
    "fr_ingredients": "exametazime",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "five-unit package",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151127,
    "drug": {
      "current_status": "MARKETED",
      "id": 21036,
      "drug_code": 83266,
      "updated_date": "2025-05-15T02:32:39-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8257463,
          "ingredient": {
            "id": 1540,
            "ingredient_code": 188,
            "en_name": "CEFPROZIL",
            "fr_name": "Cefprozil (Monohydrate de cefprozil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347253",
      "brand_name": "AURO-CEFPROZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127613002"
    },
    "created_date": "2021-12-14T19:05:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347253",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-11-30T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-01T18:37:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CEFPROZIL",
    "en_drug_common_name": "CEFPROZIL",
    "fr_drug_brand_name": "Auro-Cefprozil",
    "fr_drug_common_name": "Cefprozil",
    "en_ingredients": "CEFPROZIL",
    "fr_ingredients": "Cefprozil",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151130,
    "drug": {
      "current_status": "MARKETED",
      "id": 20952,
      "drug_code": 83030,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8257419,
          "ingredient": {
            "id": 2134,
            "ingredient_code": 11118,
            "en_name": "CEFUROXIME",
            "fr_name": "Céfuroxime (Céfuroxime sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02344823",
      "brand_name": "AURO-CEFUROXIME",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122448001"
    },
    "created_date": "2021-12-14T19:08:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02344823",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-03-15T00:00:00-04:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-03-15T18:52:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CEFUROXIME",
    "en_drug_common_name": "CEFUROXIME",
    "fr_drug_brand_name": "Auro-Cefuroxime",
    "fr_drug_common_name": "Cefuroxime",
    "en_ingredients": "CEFUROXIME",
    "fr_ingredients": "Cefuroxime Axetil",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151133,
    "drug": {
      "current_status": "MARKETED",
      "id": 30946,
      "drug_code": 93095,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261435,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445670",
      "brand_name": "AURO-CELECOXIB",
      "brand_name_fr": "AURO-CÉLÉCOXIB",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2021-12-14T19:36:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445670",
    "company_name": "AURO PHARMA INC",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-01-14T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T16:38:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CELECOXIB",
    "en_drug_common_name": "CELECOXIB",
    "fr_drug_brand_name": "Auro-Célécoxib",
    "fr_drug_common_name": "Célécoxib",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's & 500's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151138,
    "drug": {
      "current_status": "MARKETED",
      "id": 11754,
      "drug_code": 69136,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254363,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8254362,
          "ingredient": {
            "id": 2000,
            "ingredient_code": 11282,
            "en_name": "SALMETEROL",
            "fr_name": "Salmétérol (Xinafoate de salmétérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02245126",
      "brand_name": "ADVAIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0238341005"
    },
    "created_date": "2021-12-14T20:28:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245126",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2022-01-19T00:00:00-05:00",
    "actual_start_date": "2021-12-09T00:00:00-05:00",
    "actual_end_date": "2022-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-19T17:32:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ADVAIR 125",
    "en_drug_common_name": "fluticasone propionate and salmeterol pressurized inhalation, suspension",
    "fr_drug_brand_name": "ADVAIR 125",
    "fr_drug_common_name": "propionate de fluticasone et salmétérol en suspension pressurisée pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE\r\nSALMETEROL",
    "fr_ingredients": "Propionate de fluticasone; Salmétérol (Xinafoate de salmétérol)",
    "drug_strength": "125MCG\r\n25MCG",
    "drug_dosage_form": "AEROSOL, METERED DOSE",
    "drug_dosage_form_fr": "Aérosol, dose mesurée",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151141,
    "drug": {
      "current_status": "MARKETED",
      "id": 6250,
      "drug_code": 43078,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253028,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02212188",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "P9370",
      "number_of_ais": "1",
      "ai_group_no": "0123238006"
    },
    "created_date": "2021-12-14T20:34:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212188",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-01-19T00:00:00-05:00",
    "actual_start_date": "2021-12-09T00:00:00-05:00",
    "actual_end_date": "2022-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-19T17:52:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "Sumatriptan succinate injection",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Solution injectable de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "6MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "2x0.5mL (Refill pack / L’emballage de recharge)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151175,
    "drug": {
      "current_status": "MARKETED",
      "id": 59757,
      "drug_code": 97159,
      "updated_date": "2025-12-03T00:34:00-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263604,
          "ingredient": {
            "id": 16025,
            "ingredient_code": 22978,
            "en_name": "LANADELUMAB",
            "fr_name": "Lanadélumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "2",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02480948",
      "brand_name": "TAKHZYRO",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0160670001"
    },
    "created_date": "2021-12-15T16:00:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02480948",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "B06AC",
    "anticipated_start_date": "2021-12-15T00:00:00-05:00",
    "estimated_end_date": "2022-01-14T00:00:00-05:00",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2022-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-13T19:31:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TAKHZYRO",
    "en_drug_common_name": "Lanadelumab Injection",
    "fr_drug_brand_name": "Takhzyro",
    "fr_drug_common_name": "Lanadelumab Injectable",
    "en_ingredients": "LANADELUMAB",
    "fr_ingredients": "Lanadelumab",
    "drug_strength": "300MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "2 mL Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151179,
    "drug": {
      "current_status": "MARKETED",
      "id": 32148,
      "drug_code": 9831,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251228,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00799998",
      "brand_name": "STERILE WATER FOR IRRIGATION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69138",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2021-12-15T16:05:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00799998",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2021-12-17T00:00:00-05:00",
    "estimated_end_date": "2022-02-11T00:00:00-05:00",
    "actual_start_date": "2021-12-17T00:00:00-05:00",
    "actual_end_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-10T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION, USP",
    "en_drug_common_name": "STERILE WATER FOR IRRIGATION, USP",
    "fr_drug_brand_name": "Eau Stérile pour Irrigation, USP",
    "fr_drug_common_name": "Eau Stérile pour Irrigation, USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "IRRIGATION\r\nIRRIGATION",
    "drug_route_fr": "Irrigation\r\nIrrigation",
    "drug_package_quantity": "500 mL (JF7113)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151182,
    "drug": {
      "current_status": "MARKETED",
      "id": 32148,
      "drug_code": 9831,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251228,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00799998",
      "brand_name": "STERILE WATER FOR IRRIGATION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69138",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2021-12-15T16:08:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00799998",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2021-12-27T00:00:00-05:00",
    "estimated_end_date": "2022-02-11T00:00:00-05:00",
    "actual_start_date": "2021-12-27T00:00:00-05:00",
    "actual_end_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-10T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION, USP",
    "en_drug_common_name": "STERILE WATER FOR IRRIGATION, USP",
    "fr_drug_brand_name": "Eau Stérile pour Irrigation, USP",
    "fr_drug_common_name": "Eau Stérile pour Irrigation, USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "IRRIGATION\r\nIRRIGATION",
    "drug_route_fr": "Irrigation\r\nIrrigation",
    "drug_package_quantity": "1000 mL (JF7114)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151185,
    "drug": {
      "current_status": "MARKETED",
      "id": 32136,
      "drug_code": 9825,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251216,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00786160",
      "brand_name": "0.9% SODIUM CHLORIDE IRRIGATION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69132",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-12-15T16:15:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786160",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2021-12-22T00:00:00-05:00",
    "estimated_end_date": "2022-02-11T00:00:00-05:00",
    "actual_start_date": "2021-12-22T00:00:00-05:00",
    "actual_end_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-10T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "0.9% SODIUM CHLORIDE IRRIGATION, USP",
    "en_drug_common_name": "0.9% SODIUM CHLORIDE IRRIGATION, USP",
    "fr_drug_brand_name": "Irrigation au Chlorure de Sodium à 0,9%, USP",
    "fr_drug_common_name": "Irrigation au Chlorure de Sodium à 0,9%, USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "IRRIGATION\r\nIRRIGATION",
    "drug_route_fr": "Irrigation\r\nIrrigation",
    "drug_package_quantity": "500 mL (JF7123)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151188,
    "drug": {
      "current_status": "MARKETED",
      "id": 32136,
      "drug_code": 9825,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251216,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00786160",
      "brand_name": "0.9% SODIUM CHLORIDE IRRIGATION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69132",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-12-15T16:17:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786160",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2021-12-29T00:00:00-05:00",
    "estimated_end_date": "2022-02-11T00:00:00-05:00",
    "actual_start_date": "2021-12-29T00:00:00-05:00",
    "actual_end_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-10T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "0.9% SODIUM CHLORIDE IRRIGATION, USP",
    "en_drug_common_name": "0.9% SODIUM CHLORIDE IRRIGATION, USP",
    "fr_drug_brand_name": "Irrigation au Chlorure de Sodium à 0,9%, USP",
    "fr_drug_common_name": "Irrigation au Chlorure de Sodium à 0,9%, USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "IRRIGATION\r\nIRRIGATION",
    "drug_route_fr": "Irrigation\r\nIrrigation",
    "drug_package_quantity": "1000 mL (JF7124)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151195,
    "drug": {
      "current_status": "MARKETED",
      "id": 101200,
      "drug_code": 99680,
      "updated_date": "2020-12-09T00:57:54-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265754,
          "ingredient": {
            "id": 3700,
            "ingredient_code": 5525,
            "en_name": "SODIUM NITROPRUSSIDE",
            "fr_name": "Nitroprussiate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02507404",
      "brand_name": "SODIUM NITROPRUSSIDE FOR INJECTION",
      "brand_name_fr": "NITROPRUSSIATE DE SODIUM POUR INJECTION",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110498002"
    },
    "created_date": "2021-12-15T18:39:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02507404",
    "company_name": "DR REDDY'S LABORATORIES LTD",
    "atc_number": "C02DD",
    "atc_description": "ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",
    "anticipated_start_date": "2021-12-15T00:00:00-05:00",
    "estimated_end_date": "2022-02-09T00:00:00-05:00",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-10T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Please contact customer service 1-855-550-5528 (Monday to Friday from: 9:00 am to 5:00 pm ET).",
    "fr_comments": "Veuillez contacter le service à la clientèle au 1-855-550-5528 (du lundi au vendredi de 9h00 à 17h00 HE).",
    "en_drug_brand_name": "SODIUM NITROPRUSSIDE FOR INJECTION",
    "en_drug_common_name": "Sodium Nitroprusside for Injection",
    "fr_drug_brand_name": "Nitroprussiate de sodium pour injection",
    "fr_drug_common_name": "Nitroprussiate de sodium pour injection",
    "en_ingredients": "SODIUM NITROPRUSSIDE",
    "fr_ingredients": "Nitroprussiate de sodium",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 vial / carton",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151198,
    "drug": {
      "current_status": "MARKETED",
      "id": 20814,
      "drug_code": 82675,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257364,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341212",
      "brand_name": "BUTRANS 10",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241007"
    },
    "created_date": "2021-12-15T19:19:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341212",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AE",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2021-12-15T00:00:00-05:00",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2021-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-21T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Product is under investigation",
    "fr_comments": "Le produit fait l’objet d’une enquête",
    "en_drug_brand_name": "BUTRANS 10",
    "en_drug_common_name": "Buprenorphine Transdermal System",
    "fr_drug_brand_name": "BuTrans",
    "fr_drug_common_name": "Système transdermique de buprénorphine",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "10MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151221,
    "drug": {
      "current_status": "MARKETED",
      "id": 3462,
      "drug_code": 18750,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252369,
          "ingredient": {
            "id": 808,
            "ingredient_code": 7627,
            "en_name": "PREDNISOLONE SODIUM PHOSPHATE",
            "fr_name": "Phosphate sodique de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148498",
      "brand_name": "MINIMS PREDNISOLONE SODIUM PHOSPHATE",
      "brand_name_fr": "MINIMS PHOSPHATE SODIQUE DE PREDNISOLONE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81024",
      "number_of_ais": "1",
      "ai_group_no": "0106288003"
    },
    "created_date": "2021-12-15T21:15:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148498",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2021-12-27T00:00:00-05:00",
    "actual_start_date": "2021-12-10T00:00:00-05:00",
    "actual_end_date": "2022-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-02-09T21:24:51-05:00",
    "status": "resolved",
    "en_comments": "production delay",
    "fr_comments": "délai en production",
    "en_drug_brand_name": "MINIMS PREDNISOLONE SODIUM PHOSPHATE",
    "en_drug_common_name": "MINIMS PREDNISOLONE SODIUM PHOSPHATE",
    "fr_drug_brand_name": "MINIMS PREDNISOLONE SODIUM PHOSPHATE",
    "fr_drug_common_name": "MINIMS PREDNISOLONE SODIUM PHOSPHATE",
    "en_ingredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "fr_ingredients": "Phosphate sodique de prednisolone",
    "drug_strength": "0.5%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151224,
    "drug": {
      "current_status": "MARKETED",
      "id": 3474,
      "drug_code": 18758,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252375,
          "ingredient": {
            "id": 1244,
            "ingredient_code": 5843,
            "en_name": "TROPICAMIDE",
            "fr_name": "Tropicamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148536",
      "brand_name": "MINIMS TROPICAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81032",
      "number_of_ais": "1",
      "ai_group_no": "0107663001"
    },
    "created_date": "2021-12-15T21:18:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148536",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "S01FA",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "estimated_end_date": "2022-01-10T00:00:00-05:00",
    "actual_start_date": "2021-12-10T00:00:00-05:00",
    "actual_end_date": "2022-01-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-02-17T18:56:37-05:00",
    "status": "resolved",
    "en_comments": "delay in production",
    "fr_comments": "délai en production",
    "en_drug_brand_name": "MINIMS TROPICAMIDE",
    "en_drug_common_name": "MINIMS TROPICAMIDE",
    "fr_drug_brand_name": "MINIMS TROPICAMIDE",
    "fr_drug_common_name": "MINIMS TROPICAMIDE",
    "en_ingredients": "TROPICAMIDE",
    "fr_ingredients": "Tropicamide",
    "drug_strength": "1%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151229,
    "drug": {
      "current_status": "MARKETED",
      "id": 10430,
      "drug_code": 65671,
      "updated_date": "2025-12-03T00:30:44-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253938,
          "ingredient": {
            "id": 718,
            "ingredient_code": 10271,
            "en_name": "MEPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mépivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242001",
      "brand_name": "CARBOCAINE 2%",
      "brand_name_fr": "",
      "descriptor": "20ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100583002"
    },
    "created_date": "2021-12-15T21:36:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242001",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2022-01-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T18:29:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CARBOCAINE 2%",
    "en_drug_common_name": "CARBOCAINE 2%",
    "fr_drug_brand_name": "CARBOCAINE 2%",
    "fr_drug_common_name": "CARBOCAINE 2%",
    "en_ingredients": "MEPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mépivacaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nINTRACAUDAL\r\nEPIDURAL\r\nINTRACAUDAL",
    "drug_route_fr": "Épidurale\r\nIntracaudale\r\nÉpidurale\r\nIntracaudale",
    "drug_package_quantity": "10 x 20mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151232,
    "drug": {
      "current_status": "DORMANT",
      "id": 7932,
      "drug_code": 5156,
      "updated_date": "2025-12-03T02:32:12-05:00",
      "company": {
        "id": 366,
        "created_date": "2017-03-09T13:22:43-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 14115,
        "mfr_code": "",
        "name": "XEDITON PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "402",
        "street_name": "2020 WINSTON PARK DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6X7",
        "post_office_box": "",
        "contact_information": "george.gafrey@xediton.com"
      },
      "drug_ingredients": [
        {
          "id": 8366297,
          "ingredient": {
            "id": 284,
            "ingredient_code": 2144,
            "en_name": "PINDOLOL",
            "fr_name": "Pindolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8366296,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00568627",
      "brand_name": "VISKAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59809",
      "number_of_ais": "2",
      "ai_group_no": "0215487001"
    },
    "created_date": "2021-12-15T21:45:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00568627",
    "company_name": "XEDITON PHARMACEUTICALS INC",
    "atc_number": "C07CA",
    "atc_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
    "anticipated_start_date": "2021-12-20T00:00:00-05:00",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-27T13:02:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VISKAZIDE",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE PINDOLOL",
    "fr_drug_brand_name": "Viskazide",
    "fr_drug_common_name": "Hydrochlorothiazide Pindolol",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nPINDOLOL",
    "fr_ingredients": "Hydrochlorothiazide\r\nPindolol",
    "drug_strength": "25MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Pack of 3 x 35 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151235,
    "drug": {
      "current_status": "DORMANT",
      "id": 7934,
      "drug_code": 5157,
      "updated_date": "2025-12-03T02:32:12-05:00",
      "company": {
        "id": 366,
        "created_date": "2017-03-09T13:22:43-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 14115,
        "mfr_code": "",
        "name": "XEDITON PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "402",
        "street_name": "2020 WINSTON PARK DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6X7",
        "post_office_box": "",
        "contact_information": "george.gafrey@xediton.com"
      },
      "drug_ingredients": [
        {
          "id": 8366299,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8366298,
          "ingredient": {
            "id": 284,
            "ingredient_code": 2144,
            "en_name": "PINDOLOL",
            "fr_name": "Pindolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00568635",
      "brand_name": "VISKAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59810",
      "number_of_ais": "2",
      "ai_group_no": "0215487002"
    },
    "created_date": "2021-12-15T21:48:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00568635",
    "company_name": "XEDITON PHARMACEUTICALS INC",
    "atc_number": "C07CA",
    "atc_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
    "anticipated_start_date": "2021-12-20T00:00:00-05:00",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-27T13:02:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VISKAZIDE",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE PINDOLOL",
    "fr_drug_brand_name": "Viskazide",
    "fr_drug_common_name": "Hydrochlorothiazide Pindolol",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nPINDOLOL",
    "fr_ingredients": "Hydrochlorothiazide\r\nPindolol",
    "drug_strength": "50MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "3x35 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151265,
    "drug": {
      "current_status": "MARKETED",
      "id": 20174,
      "drug_code": 81614,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8257155,
          "ingredient": {
            "id": 3574,
            "ingredient_code": 20504,
            "en_name": "CLOFARABINE",
            "fr_name": "Clofarabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02330407",
      "brand_name": "CLOLAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152637001"
    },
    "created_date": "2021-12-16T13:32:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330407",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "L01BB",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2022-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-25T18:10:09-04:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "CLOLAR",
    "en_drug_common_name": "Clolar",
    "fr_drug_brand_name": "CLOLAR",
    "fr_drug_common_name": "Clolar",
    "en_ingredients": "CLOFARABINE",
    "fr_ingredients": "Clofarabine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151268,
    "drug": {
      "current_status": "MARKETED",
      "id": 10746,
      "drug_code": 66484,
      "updated_date": "2025-05-15T02:31:11-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8254068,
          "ingredient": {
            "id": 1012,
            "ingredient_code": 763,
            "en_name": "ENOXAPARIN SODIUM",
            "fr_name": "Énoxaparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.8",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242692",
      "brand_name": "LOVENOX HP",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PRE-FILLED SYRINGE 120MG/0.8ML",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131860002"
    },
    "created_date": "2021-12-16T13:38:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242692",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2021-12-13T00:00:00-05:00",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-03-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-30T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "LOVENOX HP",
    "en_drug_common_name": "Lovenox HP",
    "fr_drug_brand_name": "LOVENOX HP",
    "fr_drug_common_name": "Lovenox HP",
    "en_ingredients": "ENOXAPARIN SODIUM",
    "fr_ingredients": "Énoxaparine sodique",
    "drug_strength": "120MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151275,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21196,
      "drug_code": 83571,
      "updated_date": "2025-05-15T04:16:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348819,
          "ingredient": {
            "id": 2374,
            "ingredient_code": 11368,
            "en_name": "TERAZOSIN",
            "fr_name": "Térazosine (Chlorhydrate de térazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350505",
      "brand_name": "TERAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136978004"
    },
    "created_date": "2021-12-16T14:06:08-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02350505",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_discontinuation_date": "2022-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-16T15:39:04-05:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "TERAZOSIN",
    "en_drug_common_name": "TERAZOSIN",
    "fr_drug_brand_name": "TERAZOSIN",
    "fr_drug_common_name": "TERAZOSIN",
    "en_ingredients": "TERAZOSIN",
    "fr_ingredients": "TERAZOSIN (TERAZOSIN HYDROCHLORIDE)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151278,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21190,
      "drug_code": 83568,
      "updated_date": "2025-05-15T04:16:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348816,
          "ingredient": {
            "id": 2374,
            "ingredient_code": 11368,
            "en_name": "TERAZOSIN",
            "fr_name": "Térazosine (Chlorhydrate de térazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350475",
      "brand_name": "TERAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136978001"
    },
    "created_date": "2021-12-16T14:11:29-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02350475",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_discontinuation_date": "2022-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-16T15:37:32-05:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "TERAZOSIN",
    "en_drug_common_name": "TERAZOSIN",
    "fr_drug_brand_name": "TERAZOSIN",
    "fr_drug_common_name": "TERAZOSIN",
    "en_ingredients": "TERAZOSIN",
    "fr_ingredients": "TERAZOSIN (TERAZOSIN HYDROCHLORIDE)",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151281,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21192,
      "drug_code": 83569,
      "updated_date": "2025-05-15T04:16:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348817,
          "ingredient": {
            "id": 2374,
            "ingredient_code": 11368,
            "en_name": "TERAZOSIN",
            "fr_name": "Térazosine (Chlorhydrate de térazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350483",
      "brand_name": "TERAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136978002"
    },
    "created_date": "2021-12-16T14:13:58-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02350483",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_discontinuation_date": "2021-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-16T15:32:00-05:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "TERAZOSIN",
    "en_drug_common_name": "TERAZOSIN",
    "fr_drug_brand_name": "TERAZOSIN",
    "fr_drug_common_name": "TERAZOSIN",
    "en_ingredients": "TERAZOSIN",
    "fr_ingredients": "TERAZOSIN (TERAZOSIN HYDROCHLORIDE)",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151284,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21194,
      "drug_code": 83570,
      "updated_date": "2025-05-15T04:16:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348818,
          "ingredient": {
            "id": 2374,
            "ingredient_code": 11368,
            "en_name": "TERAZOSIN",
            "fr_name": "Térazosine (Chlorhydrate de térazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350491",
      "brand_name": "TERAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136978003"
    },
    "created_date": "2021-12-16T14:15:55-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02350491",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_discontinuation_date": "2022-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-16T15:30:53-05:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "TERAZOSIN",
    "en_drug_common_name": "TERAZOSIN",
    "fr_drug_brand_name": "TERAZOSIN",
    "fr_drug_common_name": "TERAZOSIN",
    "en_ingredients": "TERAZOSIN",
    "fr_ingredients": "TERAZOSIN (TERAZOSIN HYDROCHLORIDE)",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151293,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21244,
      "drug_code": 83630,
      "updated_date": "2025-05-15T04:17:00-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348874,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351099",
      "brand_name": "LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110731002"
    },
    "created_date": "2021-12-16T15:00:58-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02351099",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2021-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-17T06:00:03-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "LORAZEPAM",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "LORAZEPAM",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "2.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151302,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25198,
      "drug_code": 87689,
      "updated_date": "2025-05-15T04:20:25-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351937,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391562",
      "brand_name": "BUPROPION SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140002"
    },
    "created_date": "2021-12-16T15:38:51-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02391562",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2021-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-17T06:00:03-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "BUPROPION SR",
    "en_drug_common_name": "BUPROPION",
    "fr_drug_brand_name": "BUPROPION",
    "fr_drug_common_name": "BUPROPION",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151307,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25200,
      "drug_code": 87690,
      "updated_date": "2025-05-15T04:20:25-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351938,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391570",
      "brand_name": "BUPROPION SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140003"
    },
    "created_date": "2021-12-16T15:39:52-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02391570",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2021-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-17T06:00:03-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "BUPROPION SR",
    "en_drug_common_name": "BUPROPION",
    "fr_drug_brand_name": "BUPROPION",
    "fr_drug_common_name": "BUPROPION",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151320,
    "drug": {
      "current_status": "MARKETED",
      "id": 13618,
      "drug_code": 73439,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254922,
          "ingredient": {
            "id": 3116,
            "ingredient_code": 1227,
            "en_name": "FLUMAZENIL",
            "fr_name": "Flumazénil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02249561",
      "brand_name": "FLUMAZENIL INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122202001"
    },
    "created_date": "2021-12-16T19:43:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249561",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2022-02-03T00:00:00-05:00",
    "actual_start_date": "2022-01-26T00:00:00-05:00",
    "actual_end_date": "2022-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-27T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FLUMAZENIL INJECTION",
    "en_drug_common_name": "FLUMAZENIL",
    "fr_drug_brand_name": "FLUMAZENIL INJECTION",
    "fr_drug_common_name": "FLUMAZENIL",
    "en_ingredients": "FLUMAZENIL",
    "fr_ingredients": "Flumazénil",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151325,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8938,
      "drug_code": 61288,
      "updated_date": "2025-12-03T01:17:15-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8325715,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237923",
      "brand_name": "AVAPRO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2021-12-16T21:20:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237923",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2022-01-17T00:00:00-05:00",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2021-12-31T00:00:00-05:00",
    "actual_end_date": "2022-08-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-08-20T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing Issue. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date",
    "fr_comments": "Problème de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "AVAPRO",
    "en_drug_common_name": "Avapro",
    "fr_drug_brand_name": "AVAPRO",
    "fr_drug_common_name": "Avapro",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151328,
    "drug": {
      "current_status": "MARKETED",
      "id": 29452,
      "drug_code": 91480,
      "updated_date": "2025-05-15T02:34:31-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8260688,
          "ingredient": {
            "id": 4002,
            "ingredient_code": 22511,
            "en_name": "ANTIHEMOPHILIC FACTOR",
            "fr_name": "Facteur Antihémophilique (Recombiné BDD), Protéine Hybride FC"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02430312",
      "brand_name": "ELOCTATE",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL (POWDER), PRE-FILLED SYRINGE (DILUENT)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0155970003"
    },
    "created_date": "2021-12-16T21:27:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02430312",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B02BD",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "estimated_end_date": "2022-03-29T00:00:00-04:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-03-29T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Eloctate product remains available for all patients.  If necessary, patients needing the 750IU vial size will have access to alternate vial sizes until resupply is available.",
    "fr_comments": "Le produit Eloctate demeure disponible pour tous les patients. Si nécessaire, les patients ayant besoin d'un flacon de 750 UI auront accès à d'autres tailles de flacon jusqu'à ce qu'un réapprovisionnement soit fait.",
    "en_drug_brand_name": "ELOCTATE",
    "en_drug_common_name": "Eloctate",
    "fr_drug_brand_name": "ELOCTATE",
    "fr_drug_common_name": "Eloctate",
    "en_ingredients": "ANTIHEMOPHILIC FACTOR",
    "fr_ingredients": "ANTIHEMOPHILIC FACTOR",
    "drug_strength": "750UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "750",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151342,
    "drug": {
      "current_status": "MARKETED",
      "id": 17034,
      "drug_code": 78060,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256008,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295296",
      "brand_name": "APO-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2021-12-17T13:25:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295296",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-01-22T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2021-01-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-18T13:57:05-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "APO-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "APO-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151345,
    "drug": {
      "current_status": "MARKETED",
      "id": 25758,
      "drug_code": 88149,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259291,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        }
      ],
      "din": "02396467",
      "brand_name": "APO-MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676009"
    },
    "created_date": "2021-12-17T13:30:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396467",
    "company_name": "APOTEX INC",
    "estimated_end_date": "2022-03-29T00:00:00-04:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-29T12:43:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "APO-MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "1.5G",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151347,
    "drug": {
      "current_status": "MARKETED",
      "id": 16412,
      "drug_code": 77207,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255851,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286629",
      "brand_name": "APO-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928002"
    },
    "created_date": "2021-12-17T13:36:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286629",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-06T22:00:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "APO-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151360,
    "drug": {
      "current_status": "MARKETED",
      "id": 26652,
      "drug_code": 88948,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259609,
          "ingredient": {
            "id": 3336,
            "ingredient_code": 19840,
            "en_name": "RASAGILINE",
            "fr_name": "Rasagiline (Mésylate de rasagiline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02404680",
      "brand_name": "APO-RASAGILINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151662001"
    },
    "created_date": "2021-12-17T13:53:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02404680",
    "company_name": "APOTEX INC",
    "atc_number": "N04BD",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2022-09-09T00:00:00-04:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-01T13:22:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RASAGILINE",
    "en_drug_common_name": "RASAGILINE",
    "fr_drug_brand_name": "APO-RASAGILINE",
    "fr_drug_common_name": "RASAGILINE",
    "en_ingredients": "RASAGILINE",
    "fr_ingredients": "RASAGILINE",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151367,
    "drug": {
      "current_status": "MARKETED",
      "id": 26654,
      "drug_code": 88949,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259610,
          "ingredient": {
            "id": 3336,
            "ingredient_code": 19840,
            "en_name": "RASAGILINE",
            "fr_name": "Rasagiline (Mésylate de rasagiline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02404699",
      "brand_name": "APO-RASAGILINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151662002"
    },
    "created_date": "2021-12-17T14:01:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02404699",
    "company_name": "APOTEX INC",
    "atc_number": "N04BD",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2022-09-09T00:00:00-04:00",
    "actual_start_date": "2021-12-13T00:00:00-05:00",
    "actual_end_date": "2022-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-01T13:22:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RASAGILINE",
    "en_drug_common_name": "RASAGILINE",
    "fr_drug_brand_name": "APO-RASAGILINE",
    "fr_drug_common_name": "RASAGILINE",
    "en_ingredients": "RASAGILINE",
    "fr_ingredients": "RASAGILINE",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151372,
    "drug": {
      "current_status": "MARKETED",
      "id": 4740,
      "drug_code": 2527,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250423,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "149",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037869",
      "brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50067",
      "number_of_ais": "1",
      "ai_group_no": "0100273006"
    },
    "created_date": "2021-12-17T14:23:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037869",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2021-12-16T00:00:00-05:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP",
    "en_drug_common_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP",
    "fr_drug_brand_name": "Chlorure de potassium pour injection USP",
    "fr_drug_common_name": "Chlorure de potassium pour injection USP",
    "en_ingredients": "POTASSIUM CHLORIDE",
    "fr_ingredients": "Chlorure de potassium",
    "drug_strength": "149MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25 x 10mL vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151381,
    "drug": {
      "current_status": "MARKETED",
      "id": 9466,
      "drug_code": 62836,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253686,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239367",
      "brand_name": "TEVA-SUMATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238001"
    },
    "created_date": "2021-12-17T15:02:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239367",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-02T06:00:07-05:00",
    "status": "resolved",
    "en_comments": "Item is on Suspended Supply",
    "en_drug_brand_name": "TEVA-SUMATRIPTAN",
    "en_drug_common_name": "TEVA-SUMATRIPTAN 100MG TAB",
    "fr_drug_brand_name": "TEVA-SUMATRIPTAN 100MG TAB",
    "fr_drug_common_name": "TEVA-SUMATRIPTAN 100MG TAB",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151398,
    "drug": {
      "current_status": "MARKETED",
      "id": 27110,
      "drug_code": 89362,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8259772,
          "ingredient": {
            "id": 3868,
            "ingredient_code": 22120,
            "en_name": "VILANTEROL",
            "fr_name": "Vilantérol (Trifénatate de vilantérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8259771,
          "ingredient": {
            "id": 3406,
            "ingredient_code": 20155,
            "en_name": "FLUTICASONE FUROATE",
            "fr_name": "Furoate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02408872",
      "brand_name": "BREO ELLIPTA",
      "brand_name_fr": "",
      "descriptor": "POWDER IN BLISTERS FOR ORAL INHALATION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0254450003"
    },
    "created_date": "2021-12-17T15:20:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408872",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2022-01-04T00:00:00-05:00",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2022-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-05T19:53:17-05:00",
    "status": "resolved",
    "en_comments": "Managing supply due to high demand.",
    "fr_comments": "Nous gérons l’approvisionnement en raison de la très forte demande.",
    "en_drug_brand_name": "BREO ELLIPTA",
    "en_drug_common_name": "fluticasone furoate/vilanterol (as trifenatate) dry powder for oral inhalation",
    "fr_drug_brand_name": "BREO ELLIPTA",
    "fr_drug_common_name": "furoate de fluticasone et vilantérol (sous forme de trifénatate) en poudre sèche pour inhalation par voie orale",
    "en_ingredients": "FLUTICASONE FUROATE\r\nVILANTEROL",
    "fr_ingredients": "Furoate de fluticasone; Vilantérol (Trifénatate de vilantérol)",
    "drug_strength": "100MCG\r\n25MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151401,
    "drug": {
      "current_status": "MARKETED",
      "id": 30810,
      "drug_code": 92906,
      "updated_date": "2025-05-15T02:34:59-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8261377,
          "ingredient": {
            "id": 3406,
            "ingredient_code": 20155,
            "en_name": "FLUTICASONE FUROATE",
            "fr_name": "Furoate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8261376,
          "ingredient": {
            "id": 3868,
            "ingredient_code": 22120,
            "en_name": "VILANTEROL",
            "fr_name": "Vilantérol (Trifénatate de vilantérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02444186",
      "brand_name": "BREO ELLIPTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0254450004"
    },
    "created_date": "2021-12-17T15:24:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444186",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2022-01-04T00:00:00-05:00",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2022-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-05T19:54:41-05:00",
    "status": "resolved",
    "en_comments": "Managing supply due to high demand.",
    "fr_comments": "Nous gérons l’approvisionnement en raison de la très forte demande.",
    "en_drug_brand_name": "BREO ELLIPTA",
    "en_drug_common_name": "fluticasone furoate/vilanterol (as trifenatate) dry powder for oral inhalation",
    "fr_drug_brand_name": "BREO ELLIPTA",
    "fr_drug_common_name": "furoate de fluticasone et vilantérol (sous forme de trifénatate) en poudre sèche pour inhalation par voie orale",
    "en_ingredients": "VILANTEROL\r\nFLUTICASONE FUROATE",
    "fr_ingredients": "Vilantérol (Trifénatate de vilantérol); Furoate de fluticasone",
    "drug_strength": "25MCG\r\n200MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151406,
    "drug": {
      "current_status": "MARKETED",
      "id": 11504,
      "drug_code": 68259,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254280,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02244292",
      "brand_name": "FLOVENT HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685004"
    },
    "created_date": "2021-12-17T15:32:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244292",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-02-09T00:00:00-05:00",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2022-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-09T15:20:19-05:00",
    "status": "resolved",
    "en_comments": "Managing supply due to high demand.",
    "fr_comments": "Nous gérons l’approvisionnement en raison de la très forte demande.",
    "en_drug_brand_name": "FLOVENT HFA",
    "en_drug_common_name": "fluticasone propionate inhalation aerosol",
    "fr_drug_brand_name": "FLOVENT HFA",
    "fr_drug_common_name": "propionate de fluticasone en aérosol pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "125MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "ORAL\r\nINHALATION\r\nORAL\r\nINHALATION",
    "drug_route_fr": "Orale\r\nInhalation\r\nOrale\r\nInhalation",
    "drug_package_quantity": "1x120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151419,
    "drug": {
      "current_status": "MARKETED",
      "id": 18386,
      "drug_code": 79654,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256442,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310929",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2021-12-17T15:37:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310929",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-20T14:39:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 80MG FC TABLETS",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 80MG FC TABLETS",
    "fr_drug_common_name": "ATORVASTATIN 80MG FC TABLETS",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151422,
    "drug": {
      "current_status": "MARKETED",
      "id": 11508,
      "drug_code": 68260,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254281,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02244293",
      "brand_name": "FLOVENT HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685003"
    },
    "created_date": "2021-12-17T15:37:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244293",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-01-04T00:00:00-05:00",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2022-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-05T20:32:01-05:00",
    "status": "resolved",
    "en_comments": "Managing supply due to high demand.",
    "fr_comments": "Nous gérons l’approvisionnement en raison de la très forte demande.",
    "en_drug_brand_name": "FLOVENT HFA",
    "en_drug_common_name": "fluticasone propionate inhalation aerosol",
    "fr_drug_brand_name": "FLOVENT HFA",
    "fr_drug_common_name": "propionate de fluticasone en aérosol pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "250MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "ORAL\r\nINHALATION\r\nORAL\r\nINHALATION",
    "drug_route_fr": "Orale\r\nInhalation\r\nOrale\r\nInhalation",
    "drug_package_quantity": "1x120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151433,
    "drug": {
      "current_status": "MARKETED",
      "id": 18832,
      "drug_code": 80096,
      "updated_date": "2025-12-03T00:31:21-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256582,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02315424",
      "brand_name": "TEVA-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663003"
    },
    "created_date": "2021-12-17T15:54:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315424",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2022-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-26T17:40:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN 250MG FC TAB",
    "fr_drug_brand_name": "ACT-LEVOFLOXACIN 250MG FC TAB",
    "fr_drug_common_name": "LEVOFLOXACIN 250MG FC TAB",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151436,
    "drug": {
      "current_status": "MARKETED",
      "id": 2114,
      "drug_code": 14487,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251968,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01994344",
      "brand_name": "SOFLAX CAPSULES 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76120",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2021-12-17T15:55:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01994344",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AA",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2022-03-15T00:00:00-04:00",
    "actual_start_date": "2021-12-16T00:00:00-05:00",
    "actual_end_date": "2022-02-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-07T19:25:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SOFLAX CAPSULES 100MG",
    "en_drug_common_name": "SOFLAX",
    "fr_drug_brand_name": "SOFLAX CAPSULES 100MG",
    "fr_drug_common_name": "SOFLAX",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151439,
    "drug": {
      "current_status": "MARKETED",
      "id": 9938,
      "drug_code": 6419,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250892,
          "ingredient": {
            "id": 582,
            "ingredient_code": 8231,
            "en_name": "BUTALBITAL",
            "fr_name": "Butalbital"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250891,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "330",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250890,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250889,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00608181",
      "brand_name": "TEVA-TECNAL C 1/2",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63008",
      "number_of_ais": "4",
      "ai_group_no": "0401238001"
    },
    "created_date": "2021-12-17T15:55:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00608181",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2022-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-24T14:47:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TECNAL C 1/2",
    "en_drug_common_name": "TECNAL C-1/2 CAPS",
    "fr_drug_brand_name": "TEVA-TECNAL C-1/2 CAPS",
    "fr_drug_common_name": "TECNAL C-1/2 CAPS",
    "en_ingredients": "CODEINE PHOSPHATE\r\nACETYLSALICYLIC ACID\r\nCAFFEINE\r\nBUTALBITAL",
    "fr_ingredients": "Phosphate de codéine\r\nAcide acétylsalicylique\r\nCaféine\r\nButalbital",
    "drug_strength": "30MG\r\n330MG\r\n40MG\r\n50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151442,
    "drug": {
      "current_status": "MARKETED",
      "id": 2114,
      "drug_code": 14487,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251968,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01994344",
      "brand_name": "SOFLAX CAPSULES 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76120",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2021-12-17T15:56:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01994344",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AA",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2022-03-17T00:00:00-04:00",
    "actual_start_date": "2021-12-16T00:00:00-05:00",
    "actual_end_date": "2022-02-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-07T19:25:35-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SOFLAX CAPSULES 100MG",
    "en_drug_common_name": "SOFLAX",
    "fr_drug_brand_name": "SOFLAX CAPSULES 100MG",
    "fr_drug_common_name": "SOFLAX",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151445,
    "drug": {
      "current_status": "MARKETED",
      "id": 28154,
      "drug_code": 90301,
      "updated_date": "2025-05-15T02:34:11-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260230,
          "ingredient": {
            "id": 3336,
            "ingredient_code": 19840,
            "en_name": "RASAGILINE",
            "fr_name": "Rasagiline (Mésylate de rasagiline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02418444",
      "brand_name": "TEVA-RASAGILINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151662002"
    },
    "created_date": "2021-12-17T15:59:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418444",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BD",
    "atc_description": "DOPAMINERGIC AGENTS",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2021-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-22T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RASAGILINE",
    "en_drug_common_name": "RASAGILINE 1MG TAB",
    "fr_drug_brand_name": "RASAGILINE 1MG TAB",
    "fr_drug_common_name": "RASAGILINE 1MG TAB",
    "en_ingredients": "RASAGILINE",
    "fr_ingredients": "RASAGILINE",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151448,
    "drug": {
      "current_status": "MARKETED",
      "id": 55425,
      "drug_code": 95418,
      "updated_date": "2025-05-15T02:35:55-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262596,
          "ingredient": {
            "id": 198,
            "ingredient_code": 7581,
            "en_name": "BUDESONIDE",
            "fr_name": "Budésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02465957",
      "brand_name": "TEVA-BUDESONIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116807011"
    },
    "created_date": "2021-12-17T16:01:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02465957",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-12-15T00:00:00-05:00",
    "actual_end_date": "2022-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-05T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BUDESONIDE",
    "en_drug_common_name": "TEVA-BUDESONIDE INH 0.5MG/ML 2ML",
    "fr_drug_brand_name": "TEVA-BUDESONIDE INH 0.5MG/ML 2ML",
    "fr_drug_common_name": "BUDESONIDE INH 0.5MG/ML 2ML",
    "en_ingredients": "BUDESONIDE",
    "fr_ingredients": "Budésonide",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151453,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 32170,
      "drug_code": 9888,
      "updated_date": "2025-12-03T01:04:37-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8286015,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00808539",
      "brand_name": "TEVA-DICLOFENAC EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69244",
      "number_of_ais": "1",
      "ai_group_no": "0114417003"
    },
    "created_date": "2021-12-17T16:03:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00808539",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-01-30T00:00:00-05:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2022-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-05T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DICLOFENAC EC",
    "en_drug_common_name": "TEVA-DICLOFENAC 25MG TAB",
    "fr_drug_brand_name": "TEVA-DICLOFENAC 25MG TAB",
    "fr_drug_common_name": "DICLOFENAC 25MG TAB",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151456,
    "drug": {
      "current_status": "MARKETED",
      "id": 1698,
      "drug_code": 13655,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251796,
          "ingredient": {
            "id": 916,
            "ingredient_code": 1395,
            "en_name": "FAMOTIDINE",
            "fr_name": "Famotidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02022141",
      "brand_name": "TEVA-FAMOTIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75088",
      "number_of_ais": "1",
      "ai_group_no": "0118722002"
    },
    "created_date": "2021-12-17T16:04:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02022141",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-20T14:40:51-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FAMOTIDINE",
    "en_drug_common_name": "FAMOTIDINE 40MG TAB",
    "fr_drug_brand_name": "TEVA-FAMOTIDINE 40MG TAB",
    "fr_drug_common_name": "FAMOTIDINE 40MG TAB",
    "en_ingredients": "FAMOTIDINE",
    "fr_ingredients": "Famotidine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151459,
    "drug": {
      "current_status": "MARKETED",
      "id": 22222,
      "drug_code": 84628,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257954,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "225",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361221",
      "brand_name": "TEVA-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121007"
    },
    "created_date": "2021-12-17T16:06:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361221",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2021-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-23T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PREGABALIN",
    "en_drug_common_name": "PREGABALIN 225MG CAPS",
    "fr_drug_brand_name": "TEVA-PREGABALIN 225MG CAPS",
    "fr_drug_common_name": "PREGABALIN 225MG CAPS",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "225MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151462,
    "drug": {
      "current_status": "MARKETED",
      "id": 10192,
      "drug_code": 651,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250173,
          "ingredient": {
            "id": 1834,
            "ingredient_code": 7234,
            "en_name": "QUININE SULFATE",
            "fr_name": "Sulfate de quinine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00021008",
      "brand_name": "TEVA-QUININE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "25973",
      "number_of_ais": "1",
      "ai_group_no": "0106604001"
    },
    "created_date": "2021-12-17T16:07:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00021008",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "P01BC",
    "atc_description": "ANTIMALARIALS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-20T14:41:18-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-QUININE",
    "en_drug_common_name": "QUININE 200MG CAPS",
    "fr_drug_brand_name": "TEVA-QUININE 200MG CAPS",
    "fr_drug_common_name": "QUININE 200MG CAPS",
    "en_ingredients": "QUININE SULFATE",
    "fr_ingredients": "Sulfate de quinine",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151465,
    "drug": {
      "current_status": "MARKETED",
      "id": 25918,
      "drug_code": 88283,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259354,
          "ingredient": {
            "id": 3272,
            "ingredient_code": 18175,
            "en_name": "SOLIFENACIN SUCCINATE",
            "fr_name": "Succinate de solifénacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02397900",
      "brand_name": "TEVA-SOLIFENACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151584001"
    },
    "created_date": "2021-12-17T16:10:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02397900",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2024-06-10T00:00:00-04:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2024-05-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-30T19:27:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SOLIFENACIN",
    "en_drug_common_name": "SOLIFENACIN 5MG TAB",
    "fr_drug_brand_name": "TEVA-SOLIFENACIN 5MG TAB",
    "fr_drug_common_name": "SOLIFENACIN 5MG TAB",
    "en_ingredients": "SOLIFENACIN SUCCINATE",
    "fr_ingredients": "Succinate de solifénacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151468,
    "drug": {
      "current_status": "MARKETED",
      "id": 2124,
      "drug_code": 14504,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251972,
          "ingredient": {
            "id": 1080,
            "ingredient_code": 2023,
            "en_name": "SUCRALFATE",
            "fr_name": "Sucralfate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02045702",
      "brand_name": "TEVA-SUCRALFATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76137",
      "number_of_ais": "1",
      "ai_group_no": "0114237002"
    },
    "created_date": "2021-12-17T16:11:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02045702",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BX",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-20T14:41:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SUCRALFATE",
    "en_drug_common_name": "SUCRALFATE 1GM TAB",
    "fr_drug_brand_name": "TEVA-SUCRALFATE 1GM TAB",
    "fr_drug_common_name": "SUCRALFATE 1GM TAB",
    "en_ingredients": "SUCRALFATE",
    "fr_ingredients": "Sucralfate",
    "drug_strength": "1G",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151471,
    "drug": {
      "current_status": "MARKETED",
      "id": 3204,
      "drug_code": 18191,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252260,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02144263",
      "brand_name": "TEVA-TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80413",
      "number_of_ais": "1",
      "ai_group_no": "0115713001"
    },
    "created_date": "2021-12-17T16:12:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02144263",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2021-12-14T00:00:00-05:00",
    "actual_end_date": "2021-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-23T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRAZODONE",
    "en_drug_common_name": "TRAZODONE 50MG FC TAB",
    "fr_drug_brand_name": "TEVA-TRAZODONE 50MG FC TAB",
    "fr_drug_common_name": "TRAZODONE 50MG FC TAB",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151479,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5044,
      "drug_code": 2969,
      "updated_date": "2025-05-15T03:25:38-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8274240,
          "ingredient": {
            "id": 1884,
            "ingredient_code": 20656,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 22F"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274239,
          "ingredient": {
            "id": 1860,
            "ingredient_code": 20544,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 7F"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274238,
          "ingredient": {
            "id": 1878,
            "ingredient_code": 20653,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 17F"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274237,
          "ingredient": {
            "id": 1882,
            "ingredient_code": 20655,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 20"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274236,
          "ingredient": {
            "id": 1852,
            "ingredient_code": 20534,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 6B"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274235,
          "ingredient": {
            "id": 1874,
            "ingredient_code": 20651,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 12F"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274234,
          "ingredient": {
            "id": 1870,
            "ingredient_code": 20649,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 10A"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274233,
          "ingredient": {
            "id": 1844,
            "ingredient_code": 20530,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 18C"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274232,
          "ingredient": {
            "id": 1858,
            "ingredient_code": 20541,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 5"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274231,
          "ingredient": {
            "id": 1872,
            "ingredient_code": 20650,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 11A"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274230,
          "ingredient": {
            "id": 1876,
            "ingredient_code": 20652,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 15B"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274229,
          "ingredient": {
            "id": 1848,
            "ingredient_code": 20532,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 23F"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274228,
          "ingredient": {
            "id": 1862,
            "ingredient_code": 20552,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274227,
          "ingredient": {
            "id": 1856,
            "ingredient_code": 20539,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274226,
          "ingredient": {
            "id": 1864,
            "ingredient_code": 20646,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 2"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274225,
          "ingredient": {
            "id": 1868,
            "ingredient_code": 20648,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 9N"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274224,
          "ingredient": {
            "id": 1854,
            "ingredient_code": 20536,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 9V"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274223,
          "ingredient": {
            "id": 1880,
            "ingredient_code": 20654,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 19A"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274222,
          "ingredient": {
            "id": 1842,
            "ingredient_code": 20528,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 14"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274221,
          "ingredient": {
            "id": 1866,
            "ingredient_code": 20647,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 8"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274220,
          "ingredient": {
            "id": 1846,
            "ingredient_code": 20531,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 19F"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274219,
          "ingredient": {
            "id": 1850,
            "ingredient_code": 20533,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 4"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8274218,
          "ingredient": {
            "id": 1886,
            "ingredient_code": 20657,
            "en_name": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F",
            "fr_name": "Polysaccharide du pneumocoque de sérotype 33F"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00431648",
      "brand_name": "PNEUMOVAX 23",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "52298",
      "number_of_ais": "23",
      "ai_group_no": "2352867001"
    },
    "created_date": "2021-12-17T19:03:46-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00431648",
    "company_name": "MERCK CANADA INC",
    "atc_number": "J07AL",
    "atc_description": "BACTERIAL VACCINES",
    "discontinuation_date": "2021-12-17T00:00:00-05:00",
    "anticipated_discontinuation_date": "2021-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Vial format replaced by syringe format.",
    "fr_discontinuation_comments": "Le format flacon est remplacé par le format seringue.",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-12-18T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "PNEUMOVAX 23",
    "en_drug_common_name": "pneumococcal vaccine, polyvalent",
    "fr_drug_brand_name": "Pneumovax 23",
    "fr_drug_common_name": "vaccin polyvalent antipneumococcique",
    "en_ingredients": "PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N\r\nPNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1",
    "fr_ingredients": "Polysaccharide du pneumocoque de sérotype 8\r\nPolysaccharide du pneumocoque de sérotype 7F\r\nPolysaccharide du pneumocoque de sérotype 6B\r\nPolysaccharide du pneumocoque de sérotype 5\r\nPolysaccharide du pneumocoque de sérotype 4\r\nPolysaccharide du pneumocoque de sérotype 3\r\nPolysaccharide du pneumocoque de sérotype 2\r\nPolysaccharide du pneumocoque de sérotype 33F\r\nPolysaccharide du pneumocoque de sérotype 23F\r\nPolysaccharide du pneumocoque de sérotype 22F\r\nPolysaccharide du pneumocoque de sérotype 20\r\nPolysaccharide du pneumocoque de sérotype 19F\r\nPolysaccharide du pneumocoque de sérotype 19A\r\nPolysaccharide du pneumocoque de sérotype 18C\r\nPolysaccharide du pneumocoque de sérotype 17F\r\nBPolysaccharide du pneumocoque de sérotype 15B\r\nPolysaccharide du pneumocoque de sérotype 14\r\nPolysaccharide du pneumocoque de sérotype 12F\r\nPolysaccharide du pneumocoque de sérotype 11A\r\nPolysaccharide du pneumocoque de sérotype 10A\r\nPolysaccharide du pneumocoque de sérotype 9V\r\nPolysaccharide du pneumocoque de sérotype 9N\r\nPolysaccharide du pneumocoque de sérotype 1",
    "drug_strength": "25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG\r\n25MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "1 DOSE VIAL & 10X1 DOSE VIAL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151507,
    "drug": {
      "current_status": "MARKETED",
      "id": 5130,
      "drug_code": 31360,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252789,
          "ingredient": {
            "id": 678,
            "ingredient_code": 10292,
            "en_name": "SODIUM ACETATE",
            "fr_name": "Acétate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "328",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139529",
      "brand_name": "SODIUM ACETATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "F8597",
      "number_of_ais": "1",
      "ai_group_no": "0113986001"
    },
    "created_date": "2021-12-17T20:44:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139529",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2023-05-31T00:00:00-04:00",
    "actual_start_date": "2023-03-10T00:00:00-05:00",
    "actual_end_date": "2023-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-06-02T02:02:09-04:00",
    "status": "resolved",
    "en_comments": "Sodium Acetate Injection, USP 4 mEq/mL SD Vial 50 mL will be available at all distribution centres by March 10, 2023. Once available, this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand of the 50 mL plus 100% of historical monthly demand of the 100 mL at a 2:1 ratio (2 vials of 50 mL = 1 vial of 100 mL).\r\nPlease refer to our recent Healthcare Professional Communication “Important Safety Information Sodium Acetate Injection, USP – Potential for the Development of Particulate Matter” dated February 23, 2023, for important guidance relating to use of this product. Please see communication for details.",
    "fr_comments": "d'Acétate de sodium injectable, USP à 4 mEq/mL en fioles DU de 50 mL sera disponible dans tous les centres de distribution d’ici le 10 mars 2023. Une fois disponible, ce produit sera placé sous allocation. Les clients sous contrat se verront attribuer 100 % de la demande mensuelle historique du 50 mL plus 100 % de la demande historique du 100 mL, selon un ratio de 2:1 (2 fioles de 50 mL = 1 fiole de 100 mL).\r\nVeuillez consulter notre récente communication aux professionnels de la santé intitulée « Renseignements importants en matière d’innocuité - Acétate de sodium injectable, USP - Possibilité de formation de matières particulaires » datée du 23 février 2023 pour obtenir des conseils importants sur l’utilisation de ce produit. Voir la communication pour plus de details.",
    "en_drug_brand_name": "SODIUM ACETATE INJECTION, USP",
    "en_drug_common_name": "Sodium Acetate Injection, USP 4 mEq/mL SD Vial 50 mL",
    "fr_drug_brand_name": "Acétate de sodium injectable, USP 4 mEq/mL, fioles DU de 50 mL",
    "fr_drug_common_name": "Acétate de sodium injectable, USP 4 mEq/mL, fioles DU de 50 mL",
    "en_ingredients": "SODIUM ACETATE",
    "fr_ingredients": "Acétate de sodium",
    "drug_strength": "328MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151510,
    "drug": {
      "current_status": "MARKETED",
      "id": 5130,
      "drug_code": 31360,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252789,
          "ingredient": {
            "id": 678,
            "ingredient_code": 10292,
            "en_name": "SODIUM ACETATE",
            "fr_name": "Acétate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "328",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139529",
      "brand_name": "SODIUM ACETATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "F8597",
      "number_of_ais": "1",
      "ai_group_no": "0113986001"
    },
    "created_date": "2021-12-17T20:45:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139529",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2022-10-31T00:00:00-04:00",
    "actual_start_date": "2022-05-16T00:00:00-04:00",
    "actual_end_date": "2022-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-09-01T21:51:17-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada is pleased to advise that supply of our Sodium Acetate Injection, USP 4 mEq/mL Maxivial® 100 mL will be available to our customers for an additional month. Allocations will be in place until August 31, 2022. Contract customers are allocated 100% of 100 mL demand plus 100% of 50 mL demand on a mL per mL basis (2 vials of 50 mL = 1 vial of 100 mL).",
    "fr_comments": "Fresenius Kabi Canada a le plaisir de vous informer que des stocks d’Acétate de sodium injectable, USP à 4 mEq/mL en MaxivialMD de 100 mL seront disponibles pour nos clients pendant un mois supplémentaire. Les allocations seront en place jusqu’au 31 août 2022. Les clients sous contrat se voient attribuer 100 % de leur demande du 100 mL plus 100 % de celle du 50 mL sur une base de mL par mL (2 fioles de 50 mL = 1 fiole de 100 mL).",
    "en_drug_brand_name": "SODIUM ACETATE INJECTION, USP",
    "en_drug_common_name": "Sodium Acetate Injection, USP 4 mEq/mL Maxivial® 100 mL",
    "fr_drug_brand_name": "Acétate de sodium injectable, USP 4 mEq/mL, MaxivialMD de 100 mL",
    "fr_drug_common_name": "Acétate de sodium injectable, USP 4 mEq/mL, MaxivialMD de 100 mL",
    "en_ingredients": "SODIUM ACETATE",
    "fr_ingredients": "Acétate de sodium",
    "drug_strength": "328MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151515,
    "drug": {
      "current_status": "MARKETED",
      "id": 10850,
      "drug_code": 66737,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254096,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242905",
      "brand_name": "MIDAZOLAM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2021-12-17T20:48:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242905",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2022-01-01T00:00:00-05:00",
    "estimated_end_date": "2022-03-18T00:00:00-04:00",
    "actual_end_date": "2022-03-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-19T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Midazolam Injection 5 mg/mL MD Vial 10 mL effective January 1, 2022 until January 31, 2022.",
    "fr_comments": "Au nom de Fresenius Kabi Canada, j’ai le regret de vous aviser qu’en raison d’un retard de production, nous allons éprouver une interruption d’approvisionnement qui va toucher notre préparation de Midazolam injectable, 5 mg/mL, fioles DM de 10 mL à compter 1 janvier 2022 et jusqu’au 31 janvier 2022.",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam Injection 5 mg/mL MD Vial 10 mL",
    "fr_drug_brand_name": "Midazolam injectable, 5 mg/mL, fioles DM de 10 mL",
    "fr_drug_common_name": "Midazolam injectable, 5 mg/mL, fioles DM de 10 mL",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151576,
    "drug": {
      "current_status": "MARKETED",
      "id": 22024,
      "drug_code": 84395,
      "updated_date": "2025-05-15T02:32:50-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257884,
          "ingredient": {
            "id": 2466,
            "ingredient_code": 11561,
            "en_name": "OLOPATADINE",
            "fr_name": "Olopatadine (Chlorhydrate d'olopatadine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02358913",
      "brand_name": "SANDOZ OLOPATADINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132394001"
    },
    "created_date": "2021-12-20T16:40:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02358913",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01GX",
    "atc_description": "DECONGESTANTS AND ANTIALLERGICS",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2021-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-30T18:25:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLOPATADINE",
    "en_drug_common_name": "OLOPATADINE",
    "fr_drug_brand_name": "SANDOZ OLOPATADINE",
    "fr_drug_common_name": "OLOPATADINE",
    "en_ingredients": "OLOPATADINE",
    "fr_ingredients": "OLOPATADINE",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML 1LDP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151585,
    "drug": {
      "current_status": "MARKETED",
      "id": 98819,
      "drug_code": 93938,
      "updated_date": "2020-04-03T06:53:05-04:00",
      "company": {
        "id": 1020,
        "created_date": "2017-03-09T13:23:37-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 13175,
        "mfr_code": "",
        "name": "UCB CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "602",
        "street_name": "2201 BRISTOL CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0J8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261842,
          "ingredient": {
            "id": 4154,
            "ingredient_code": 22702,
            "en_name": "BRIVARACETAM",
            "fr_name": "BRIVARACÉTAM"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02452987",
      "brand_name": "BRIVLERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157931001"
    },
    "created_date": "2021-12-20T16:47:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452987",
    "company_name": "UCB CANADA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2021-12-23T00:00:00-05:00",
    "estimated_end_date": "2022-01-24T00:00:00-05:00",
    "actual_start_date": "2022-01-04T00:00:00-05:00",
    "actual_end_date": "2022-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-19T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BRIVLERA",
    "en_drug_common_name": "BRIVLERA",
    "fr_drug_brand_name": "BRIVLERA",
    "fr_drug_common_name": "BRIVLERA",
    "en_ingredients": "BRIVARACETAM",
    "fr_ingredients": "BRIVARACÉTAM",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "300mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151588,
    "drug": {
      "current_status": "MARKETED",
      "id": 9774,
      "drug_code": 63823,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253752,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240285",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935002"
    },
    "created_date": "2021-12-20T16:48:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240285",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:39:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "5ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151591,
    "drug": {
      "current_status": "MARKETED",
      "id": 21018,
      "drug_code": 83249,
      "updated_date": "2025-05-15T02:32:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257457,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347091",
      "brand_name": "SANDOZ VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626001"
    },
    "created_date": "2021-12-20T16:51:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347091",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2022-01-14T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-19T03:03:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALACYCLOVIR",
    "en_drug_common_name": "VALACYCLOVIR",
    "fr_drug_brand_name": "SANDOZ VALACYCLOVIR",
    "fr_drug_common_name": "VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151594,
    "drug": {
      "current_status": "MARKETED",
      "id": 9776,
      "drug_code": 63824,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253753,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240286",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2021-12-20T16:53:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240286",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:39:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151597,
    "drug": {
      "current_status": "MARKETED",
      "id": 27372,
      "drug_code": 89614,
      "updated_date": "2025-05-15T02:34:02-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259903,
          "ingredient": {
            "id": 2840,
            "ingredient_code": 12034,
            "en_name": "MOXIFLOXACIN",
            "fr_name": "Moxifloxacine (Chlorhydrate de moxifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02411520",
      "brand_name": "SANDOZ MOXIFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142242003"
    },
    "created_date": "2021-12-20T16:55:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411520",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01AE",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2022-01-14T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-19T03:06:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MOXIFLOXACIN",
    "en_drug_common_name": "MOXIFLOXACIN",
    "fr_drug_brand_name": "SANDOZ MOXIFLOXACIN",
    "fr_drug_common_name": "MOXIFLOXACIN",
    "en_ingredients": "MOXIFLOXACIN",
    "fr_ingredients": "MOXIFLOXACIN",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "3ML LDP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151600,
    "drug": {
      "current_status": "MARKETED",
      "id": 12436,
      "drug_code": 71020,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254578,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246820",
      "brand_name": "SANDOZ METFORMIN FC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2021-12-20T16:57:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246820",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2021-12-24T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2021-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-30T18:26:18-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ METFORMIN FC",
    "en_drug_common_name": "METFORMIN",
    "fr_drug_brand_name": "SANDOZ METFORMIN FC",
    "fr_drug_common_name": "METFORMIN",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "360FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151603,
    "drug": {
      "current_status": "MARKETED",
      "id": 11056,
      "drug_code": 67176,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254155,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243278",
      "brand_name": "LORAZEPAM INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110731004"
    },
    "created_date": "2021-12-20T16:59:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243278",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2022-01-21T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2021-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-12-30T18:24:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LORAZEPAM INJECTION USP",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "LORAZEPAM INJECTION USP",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "4MG",
    "drug_dosage_form": "SOLUTION\r\nLIQUID",
    "drug_dosage_form_fr": "Solution\r\nLiquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151607,
    "drug": {
      "current_status": "MARKETED",
      "id": 31914,
      "drug_code": 94438,
      "updated_date": "2025-12-03T00:33:11-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262104,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457326",
      "brand_name": "SANDOZ AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310004"
    },
    "created_date": "2021-12-20T17:01:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457326",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:16:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR",
    "fr_drug_brand_name": "SANDOZ AMPHETAMINE XR",
    "fr_drug_common_name": "AMPHETAMINE XR",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "AMPHETAMINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRCH BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151610,
    "drug": {
      "current_status": "MARKETED",
      "id": 19932,
      "drug_code": 81245,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256968,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02327139",
      "brand_name": "SANDOZ FENTANYL PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302016"
    },
    "created_date": "2021-12-20T17:03:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327139",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:37:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "en_drug_common_name": "FENTANYL PATCH",
    "fr_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "fr_drug_common_name": "FENTANYL PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "37MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5TTSS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151613,
    "drug": {
      "current_status": "MARKETED",
      "id": 63376,
      "drug_code": 95822,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262832,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02469421",
      "brand_name": "SANDOZ HYDROCORTISONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106344008"
    },
    "created_date": "2021-12-20T17:05:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469421",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-30T01:53:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ HYDROCORTISONE",
    "en_drug_common_name": "HYDROCORTISONE",
    "fr_drug_brand_name": "SANDOZ HYDROCORTISONE",
    "fr_drug_common_name": "HYDROCORTISONE",
    "en_ingredients": "HYDROCORTISONE",
    "fr_ingredients": "Hydrocortisone",
    "drug_strength": "2.5%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "225G JA",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151616,
    "drug": {
      "current_status": "MARKETED",
      "id": 19928,
      "drug_code": 81243,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256966,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02327112",
      "brand_name": "SANDOZ FENTANYL PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302015"
    },
    "created_date": "2021-12-20T17:07:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327112",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:26:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "en_drug_common_name": "FENTANYL PATCH",
    "fr_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "fr_drug_common_name": "FENTANYL PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "12MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5TTSS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151621,
    "drug": {
      "current_status": "MARKETED",
      "id": 31466,
      "drug_code": 93784,
      "updated_date": "2025-05-15T02:35:14-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8261722,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261721,
          "ingredient": {
            "id": 4138,
            "ingredient_code": 16100,
            "en_name": "PERINDOPRIL ARGININE",
            "fr_name": "Périndopril arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "14",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02451557",
      "brand_name": "VIACORAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257790003"
    },
    "created_date": "2021-12-20T18:53:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02451557",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "C09BB",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "anticipated_start_date": "2021-12-22T00:00:00-05:00",
    "actual_end_date": "2022-01-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-16T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VIACORAM",
    "en_drug_common_name": "Viacoram 14 mg/10 mg",
    "fr_drug_brand_name": "Viacoram",
    "fr_drug_common_name": "Viacoram 14 mg/10 mg",
    "en_ingredients": "AMLODIPINE\r\nPERINDOPRIL ARGININE",
    "fr_ingredients": "Perindopril arginine / amlodipine",
    "drug_strength": "10MG\r\n14MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151663,
    "drug": {
      "current_status": "MARKETED",
      "id": 49642,
      "drug_code": 92813,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261324,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261323,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443449",
      "brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED-RELEASE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252870002"
    },
    "created_date": "2021-12-21T17:48:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443449",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2021-12-28T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2021-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-01-04T12:36:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "en_drug_common_name": "NAPROXEN/ESOMEPRAZOLE MR",
    "fr_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "fr_drug_common_name": "NAPROXEN/ESOMEPRAZOLE MR",
    "en_ingredients": "ESOMEPRAZOLE\r\nNAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "20MG\r\n500MG",
    "drug_dosage_form": "TABLET (IMMEDIATE AND DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate et retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151666,
    "drug": {
      "current_status": "MARKETED",
      "id": 60426,
      "drug_code": 95236,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262508,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464209",
      "brand_name": "MYLAN-VARDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003001"
    },
    "created_date": "2021-12-21T17:49:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464209",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2022-03-09T00:00:00-05:00",
    "estimated_end_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-09T21:11:57-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-VARDENAFIL",
    "en_drug_common_name": "VARDENAFIL",
    "fr_drug_brand_name": "MYLAN-VARDENAFIL",
    "fr_drug_common_name": "VARDENAFIL",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "VARDENAFIL",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4BL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151681,
    "drug": {
      "current_status": "MARKETED",
      "id": 6138,
      "drug_code": 42847,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252985,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02184443",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9014",
      "number_of_ais": "1",
      "ai_group_no": "0104545006"
    },
    "created_date": "2021-12-21T18:01:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02184443",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2021-12-28T00:00:00-05:00",
    "actual_start_date": "2021-12-01T00:00:00-05:00",
    "actual_end_date": "2021-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-04T12:34:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "MORPHINE SULFATE",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "MORPHINE SULFATE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151684,
    "drug": {
      "current_status": "MARKETED",
      "id": 8296,
      "drug_code": 5678,
      "updated_date": "2025-12-03T00:30:23-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250799,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00596434",
      "brand_name": "EPIVAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61278",
      "number_of_ais": "1",
      "ai_group_no": "0112996003"
    },
    "created_date": "2021-12-21T18:02:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00596434",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2022-02-23T00:00:00-05:00",
    "estimated_end_date": "2022-03-01T00:00:00-05:00",
    "actual_end_date": "2022-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-01-13T12:41:19-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "EPIVAL",
    "en_drug_common_name": "DIVALPROEX",
    "fr_drug_brand_name": "EPIVAL",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)\r\nTABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)\r\nComprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151687,
    "drug": {
      "current_status": "MARKETED",
      "id": 27244,
      "drug_code": 89495,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259841,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410303",
      "brand_name": "MOVISSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106372001"
    },
    "created_date": "2021-12-21T18:04:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410303",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AC",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2022-01-05T00:00:00-05:00",
    "actual_start_date": "2021-12-17T00:00:00-05:00",
    "actual_end_date": "2021-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-04T12:37:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MOVISSE",
    "en_drug_common_name": "NORETHINDRONE",
    "fr_drug_brand_name": "MOVISSE",
    "fr_drug_common_name": "NORETHINDRONE",
    "en_ingredients": "NORETHINDRONE",
    "fr_ingredients": "Noréthindrone",
    "drug_strength": "0.35MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28BL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151696,
    "drug": {
      "current_status": "DORMANT",
      "id": 29922,
      "drug_code": 91988,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369253,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02435535",
      "brand_name": "JAMP-AMITRIPTYLINE TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524002"
    },
    "created_date": "2021-12-21T20:19:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435535",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-12-31T00:00:00-05:00",
    "actual_start_date": "2021-11-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-12T17:01:00-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-AMITRIPTYLINE TABLETS",
    "en_drug_common_name": "Amitriptyline Hydrochloride Tablets",
    "fr_drug_brand_name": "JAMP-AMITRIPTYLINE TABLETS",
    "fr_drug_common_name": "Comprimés de chlorhydrate d'amitriptyline",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151699,
    "drug": {
      "current_status": "DORMANT",
      "id": 26458,
      "drug_code": 88784,
      "updated_date": "2025-05-15T06:55:49-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368929,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403005",
      "brand_name": "JAMP-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843001"
    },
    "created_date": "2021-12-21T20:22:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403005",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_start_date": "2021-12-03T00:00:00-05:00",
    "actual_end_date": "2022-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-06T20:38:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-LEVETIRACETAM",
    "en_drug_common_name": "Levetiracetam Tablets",
    "fr_drug_brand_name": "JAMP-Levetiracetam",
    "fr_drug_common_name": "Comprimés de lévétiracétam",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151702,
    "drug": {
      "current_status": "MARKETED",
      "id": 101877,
      "drug_code": 99919,
      "updated_date": "2021-06-08T05:12:49-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265910,
          "ingredient": {
            "id": 3816,
            "ingredient_code": 21466,
            "en_name": "PIRFENIDONE",
            "fr_name": "Pirfénidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "267",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02509938",
      "brand_name": "JAMP PIRFENIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153328001"
    },
    "created_date": "2021-12-21T20:38:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02509938",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2021-12-16T00:00:00-05:00",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_end_date": "2024-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-29T14:07:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP PIRFENIDONE",
    "en_drug_common_name": "Pirfenidone Capsules",
    "fr_drug_brand_name": "JAMP Pirfenidone",
    "fr_drug_common_name": "Gélules de pirfénidone",
    "en_ingredients": "PIRFENIDONE",
    "fr_ingredients": "Pirfénidone",
    "drug_strength": "267MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "63 (blister)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151705,
    "drug": {
      "current_status": "MARKETED",
      "id": 101877,
      "drug_code": 99919,
      "updated_date": "2021-06-08T05:12:49-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265910,
          "ingredient": {
            "id": 3816,
            "ingredient_code": 21466,
            "en_name": "PIRFENIDONE",
            "fr_name": "Pirfénidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "267",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02509938",
      "brand_name": "JAMP PIRFENIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153328001"
    },
    "created_date": "2021-12-21T20:41:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02509938",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2021-12-16T00:00:00-05:00",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_end_date": "2022-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-07-19T20:16:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP PIRFENIDONE",
    "en_drug_common_name": "Pirfenidone Capsules",
    "fr_drug_brand_name": "JAMP Pirfenidone",
    "fr_drug_common_name": "Gélules de pirfénidone",
    "en_ingredients": "PIRFENIDONE",
    "fr_ingredients": "Pirfénidone",
    "drug_strength": "267MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "270 (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151708,
    "drug": {
      "current_status": "MARKETED",
      "id": 101884,
      "drug_code": 100411,
      "updated_date": "2021-06-08T05:13:07-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266233,
          "ingredient": {
            "id": 3816,
            "ingredient_code": 21466,
            "en_name": "PIRFENIDONE",
            "fr_name": "Pirfénidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "801",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02514710",
      "brand_name": "JAMP PIRFENIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153328003"
    },
    "created_date": "2021-12-21T21:09:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02514710",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2021-12-16T00:00:00-05:00",
    "estimated_end_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-06T20:40:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP PIRFENIDONE",
    "en_drug_common_name": "Pirfenidone Capsules",
    "fr_drug_brand_name": "JAMP Pirfenidone",
    "fr_drug_common_name": "Gélules de pirfénidone",
    "en_ingredients": "PIRFENIDONE",
    "fr_ingredients": "Pirfénidone",
    "drug_strength": "801MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90 (Bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151711,
    "drug": {
      "current_status": "MARKETED",
      "id": 101883,
      "drug_code": 100410,
      "updated_date": "2021-06-08T05:13:06-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266232,
          "ingredient": {
            "id": 3816,
            "ingredient_code": 21466,
            "en_name": "PIRFENIDONE",
            "fr_name": "Pirfénidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "267",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02514702",
      "brand_name": "JAMP PIRFENIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153328001"
    },
    "created_date": "2021-12-21T21:11:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02514702",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2021-12-16T00:00:00-05:00",
    "estimated_end_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-06T20:41:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP PIRFENIDONE",
    "en_drug_common_name": "Pirfenidone Capsules",
    "fr_drug_brand_name": "JAMP Pirfenidone",
    "fr_drug_common_name": "Gélules de pirfénidone",
    "en_ingredients": "PIRFENIDONE",
    "fr_ingredients": "Pirfénidone",
    "drug_strength": "267MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90 (Bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151750,
    "drug": {
      "current_status": "MARKETED",
      "id": 15822,
      "drug_code": 76561,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8255667,
          "ingredient": {
            "id": 3158,
            "ingredient_code": 13348,
            "en_name": "VORICONAZOLE",
            "fr_name": "Voriconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02279991",
      "brand_name": "VFEND",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150242003"
    },
    "created_date": "2021-12-22T15:43:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279991",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "actual_start_date": "2021-12-31T00:00:00-05:00",
    "actual_end_date": "2022-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-05T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VFEND",
    "en_drug_common_name": "VFEND",
    "fr_drug_brand_name": "VFEND",
    "fr_drug_common_name": "VFEND",
    "en_ingredients": "VORICONAZOLE",
    "fr_ingredients": "Voriconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "70ml BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151759,
    "drug": {
      "current_status": "MARKETED",
      "id": 20254,
      "drug_code": 817,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250195,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037796",
      "brand_name": "SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "30210",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-12-22T17:06:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037796",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2022-01-01T00:00:00-05:00",
    "actual_end_date": "2022-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-01-20T14:50:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "SODIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "Chlorure de sodium",
    "fr_drug_common_name": "Chlorure de sodium",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAPERITONEAL\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAPERITONEAL\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntrapéritonéale\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntrapéritonéale\r\nIntramusculaire",
    "drug_package_quantity": "25 x 10mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151791,
    "drug": {
      "current_status": "MARKETED",
      "id": 54640,
      "drug_code": 95933,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262893,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470357",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548018"
    },
    "created_date": "2021-12-22T20:01:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470357",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-01-07T00:00:00-05:00",
    "estimated_end_date": "2024-12-06T00:00:00-05:00",
    "actual_start_date": "2022-01-05T00:00:00-05:00",
    "actual_end_date": "2024-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-11-26T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151794,
    "drug": {
      "current_status": "MARKETED",
      "id": 54638,
      "drug_code": 95932,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262892,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "85",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470349",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548013"
    },
    "created_date": "2021-12-22T20:03:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470349",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-01-07T00:00:00-05:00",
    "estimated_end_date": "2022-01-28T00:00:00-05:00",
    "actual_start_date": "2022-01-05T00:00:00-05:00",
    "actual_end_date": "2022-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-27T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "85MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151853,
    "drug": {
      "current_status": "MARKETED",
      "id": 5854,
      "drug_code": 4011,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250591,
          "ingredient": {
            "id": 684,
            "ingredient_code": 2011,
            "en_name": "MINOXIDIL",
            "fr_name": "Minoxidil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00514497",
      "brand_name": "LONITEN 2.5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56356",
      "number_of_ais": "1",
      "ai_group_no": "0114429002"
    },
    "created_date": "2021-12-23T01:59:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00514497",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C02DC",
    "atc_description": "ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",
    "anticipated_start_date": "2022-03-11T00:00:00-05:00",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-03-11T00:00:00-05:00",
    "actual_end_date": "2022-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LONITEN 2.5MG",
    "en_drug_common_name": "LONITEN",
    "fr_drug_brand_name": "LONITEN 2.5MG",
    "fr_drug_common_name": "LONITEN",
    "en_ingredients": "MINOXIDIL",
    "fr_ingredients": "Minoxidil",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151868,
    "drug": {
      "current_status": "MARKETED",
      "id": 11016,
      "drug_code": 67060,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254145,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "67",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243180",
      "brand_name": "AA-FENO-MICRO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895003"
    },
    "created_date": "2021-12-23T14:49:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243180",
    "company_name": "AA PHARMA INC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2021-12-23T00:00:00-05:00",
    "estimated_end_date": "2022-01-21T00:00:00-05:00",
    "actual_end_date": "2022-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-26T20:03:36-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AA-FENO-MICRO",
    "en_drug_common_name": "AA-FENO-MICRO",
    "fr_drug_brand_name": "AA-FENO-MICRO",
    "fr_drug_common_name": "AA-FENO-MICRO",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "67MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151871,
    "drug": {
      "current_status": "MARKETED",
      "id": 9530,
      "drug_code": 63101,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253703,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02239630",
      "brand_name": "TOBI",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110230004"
    },
    "created_date": "2021-12-23T14:57:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239630",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "anticipated_start_date": "2021-12-29T00:00:00-05:00",
    "estimated_end_date": "2022-03-08T00:00:00-05:00",
    "actual_end_date": "2022-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-13T12:40:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TOBI",
    "en_drug_common_name": "TOBRAMYCIN SOLUTION",
    "fr_drug_brand_name": "TOBI",
    "fr_drug_common_name": "TOBRAMYCIN SOLUTION",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "300MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "56 AMPULES",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151883,
    "drug": {
      "current_status": "MARKETED",
      "id": 16708,
      "drug_code": 77653,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255914,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02291150",
      "brand_name": "APO-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806002"
    },
    "created_date": "2021-12-24T13:26:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02291150",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-04T12:50:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "APO-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151886,
    "drug": {
      "current_status": "MARKETED",
      "id": 52151,
      "drug_code": 89791,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259958,
          "ingredient": {
            "id": 682,
            "ingredient_code": 10224,
            "en_name": "DOXYLAMINE SUCCINATE",
            "fr_name": "Succinate de doxylamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259957,
          "ingredient": {
            "id": 636,
            "ingredient_code": 5008,
            "en_name": "PYRIDOXINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de pyridoxine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413248",
      "brand_name": "APO-DOXYLAMINE/B6",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0213346001"
    },
    "created_date": "2021-12-24T13:29:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413248",
    "company_name": "APOTEX INC",
    "atc_number": "R06AA",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-14T18:22:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOXYLAMINE/B6",
    "en_drug_common_name": "DOXYLAMINE/B6",
    "fr_drug_brand_name": "APO-DOXYLAMINE/B6",
    "fr_drug_common_name": "DOXYLAMINE/B6",
    "en_ingredients": "DOXYLAMINE SUCCINATE\r\nPYRIDOXINE HYDROCHLORIDE",
    "fr_ingredients": "Succinate de doxylamine\r\nChlorhydrate de pyridoxine",
    "drug_strength": "10MG\r\n10MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151889,
    "drug": {
      "current_status": "MARKETED",
      "id": 22632,
      "drug_code": 85158,
      "updated_date": "2025-12-03T00:31:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258151,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366754",
      "brand_name": "APO-OXYCODONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552002"
    },
    "created_date": "2021-12-24T13:32:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366754",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-03-18T00:00:00-04:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2022-03-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-21T12:56:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OXYCODONE CR",
    "en_drug_common_name": "OXYCODONE",
    "fr_drug_brand_name": "APO-OXYCODONE",
    "fr_drug_common_name": "OXYCODONE",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)\r\nTABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)\r\nComprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151892,
    "drug": {
      "current_status": "MARKETED",
      "id": 11942,
      "drug_code": 69769,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254431,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02245669",
      "brand_name": "APO-SALBUTAMOL HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108887003"
    },
    "created_date": "2021-12-24T13:38:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245669",
    "company_name": "APOTEX INC",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2022-01-03T00:00:00-05:00",
    "actual_start_date": "2021-12-20T00:00:00-05:00",
    "actual_end_date": "2021-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-31T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SALBUTAMOL HFA",
    "en_drug_common_name": "SALBUTAMOL INHALER",
    "fr_drug_brand_name": "APO-SALBUTAMOL HFA",
    "fr_drug_common_name": "SALBUTAMOL INHALER",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "100MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "200MD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151908,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6916,
      "drug_code": 46885,
      "updated_date": "2025-12-03T01:13:19-05:00",
      "company": {
        "id": 674,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 6290,
        "mfr_code": "MPA95",
        "name": "MISSION PHARMACAL COMPANY",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8000 INTERSTATE HIGHWAY 10 WEST",
        "province": "TEXAS",
        "country": "UNITED STATES",
        "city": "SAN ANTONIO",
        "postal_code": "78230",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8313321,
          "ingredient": {
            "id": 2290,
            "ingredient_code": 7132,
            "en_name": "POTASSIUM CITRATE",
            "fr_name": "Citrate de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "540",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01914022",
      "brand_name": "UROCIT-K",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "Y9935",
      "number_of_ais": "1",
      "ai_group_no": "0131342002"
    },
    "created_date": "2021-12-28T19:28:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01914022",
    "company_name": "MISSION PHARMACAL COMPANY",
    "atc_number": "A12BA",
    "atc_description": "POTASSIUM",
    "anticipated_start_date": "2021-12-17T00:00:00-05:00",
    "estimated_end_date": "2022-02-15T00:00:00-05:00",
    "actual_start_date": "2021-12-17T00:00:00-05:00",
    "actual_end_date": "2022-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-02-23T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Delay from label supplier.",
    "fr_comments": "Retard du fournisseur d'étiquettes.",
    "en_drug_brand_name": "UROCIT-K",
    "en_drug_common_name": "Potassium Citrate Extended Release Tablets",
    "fr_drug_brand_name": "Urocit-K",
    "fr_drug_common_name": "Citrate de potassium",
    "en_ingredients": "POTASSIUM CITRATE",
    "fr_ingredients": "Citrate de potassium",
    "drug_strength": "540MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100-ct",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151911,
    "drug": {
      "current_status": "MARKETED",
      "id": 21536,
      "drug_code": 83921,
      "updated_date": "2025-12-03T00:31:38-05:00",
      "company": {
        "id": 674,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 6290,
        "mfr_code": "MPA95",
        "name": "MISSION PHARMACAL COMPANY",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8000 INTERSTATE HIGHWAY 10 WEST",
        "province": "TEXAS",
        "country": "UNITED STATES",
        "city": "SAN ANTONIO",
        "postal_code": "78230",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257693,
          "ingredient": {
            "id": 2290,
            "ingredient_code": 7132,
            "en_name": "POTASSIUM CITRATE",
            "fr_name": "Citrate de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1080",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353997",
      "brand_name": "UROCIT-K",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131342003"
    },
    "created_date": "2021-12-28T19:31:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353997",
    "company_name": "MISSION PHARMACAL COMPANY",
    "atc_number": "A12BA",
    "atc_description": "POTASSIUM",
    "anticipated_start_date": "2021-12-24T00:00:00-05:00",
    "estimated_end_date": "2022-02-15T00:00:00-05:00",
    "actual_start_date": "2021-12-22T00:00:00-05:00",
    "actual_end_date": "2022-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-02-23T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Delay from label supplier.",
    "fr_comments": "Retard du fournisseur d'étiquettes.",
    "en_drug_brand_name": "UROCIT-K",
    "en_drug_common_name": "Potassium Citrate Extended Release Tablets",
    "fr_drug_brand_name": "Urocit-K",
    "fr_drug_common_name": "Citrate de potassium",
    "en_ingredients": "POTASSIUM CITRATE",
    "fr_ingredients": "Citrate de potassium",
    "drug_strength": "1080MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100-ct",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151964,
    "drug": {
      "current_status": "MARKETED",
      "id": 23550,
      "drug_code": 86141,
      "updated_date": "2025-05-15T02:33:06-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258498,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375958",
      "brand_name": "SANDOZ TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2021-12-30T18:39:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375958",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-29T00:00:00-05:00",
    "actual_end_date": "2022-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:24:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "SANDOZ TELMISARTAN",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500TAB BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151967,
    "drug": {
      "current_status": "MARKETED",
      "id": 19218,
      "drug_code": 80468,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256724,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02319217",
      "brand_name": "SANDOZ TAMSULOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2021-12-30T18:40:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319217",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2022-01-14T00:00:00-05:00",
    "actual_start_date": "2021-12-29T00:00:00-05:00",
    "actual_end_date": "2022-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:54:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TAMSULOSIN",
    "en_drug_common_name": "TAMSULOSIN",
    "fr_drug_brand_name": "SANDOZ TAMSULOSIN",
    "fr_drug_common_name": "TAMSULOSIN",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRCH BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151970,
    "drug": {
      "current_status": "MARKETED",
      "id": 51281,
      "drug_code": 94883,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262335,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461323",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934002"
    },
    "created_date": "2021-12-30T18:41:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461323",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-29T00:00:00-05:00",
    "actual_end_date": "2022-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:26:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100MRT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151973,
    "drug": {
      "current_status": "MARKETED",
      "id": 14470,
      "drug_code": 74727,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255211,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261928",
      "brand_name": "SANDOZ-DICLOFENAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114417002"
    },
    "created_date": "2021-12-30T18:43:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261928",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-01-07T00:00:00-05:00",
    "actual_start_date": "2021-12-29T00:00:00-05:00",
    "actual_end_date": "2022-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-01-12T20:18:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ-DICLOFENAC",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "SANDOZ-DICLOFENAC",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "30SUP",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151976,
    "drug": {
      "current_status": "MARKETED",
      "id": 52287,
      "drug_code": 95259,
      "updated_date": "2025-05-15T02:35:52-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262525,
          "ingredient": {
            "id": 3356,
            "ingredient_code": 20022,
            "en_name": "DEFERASIROX",
            "fr_name": "Déférasirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464454",
      "brand_name": "SANDOZ DEFERASIROX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151733001"
    },
    "created_date": "2021-12-30T18:44:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464454",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AC",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2022-01-14T00:00:00-05:00",
    "actual_start_date": "2021-12-29T00:00:00-05:00",
    "actual_end_date": "2022-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-01-19T02:57:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DEFERASIROX",
    "en_drug_common_name": "DEFERASIROX",
    "fr_drug_brand_name": "SANDOZ DEFERASIROX",
    "fr_drug_common_name": "DEFERASIROX",
    "en_ingredients": "DEFERASIROX",
    "fr_ingredients": "Déférasirox",
    "drug_strength": "125MG",
    "drug_dosage_form": "TABLET FOR SUSPENSION",
    "drug_dosage_form_fr": "Comprimé pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28DT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151979,
    "drug": {
      "current_status": "MARKETED",
      "id": 19910,
      "drug_code": 81230,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256959,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326973",
      "brand_name": "SANDOZ CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2021-12-30T18:46:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326973",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-01-14T00:00:00-05:00",
    "actual_start_date": "2021-12-29T00:00:00-05:00",
    "actual_end_date": "2022-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-01-12T20:17:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "SANDOZ CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500TAB BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 151999,
    "drug": {
      "current_status": "MARKETED",
      "id": 5882,
      "drug_code": 4092,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250592,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037842",
      "brand_name": "SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56634",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2021-12-31T15:36:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037842",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-02-07T00:00:00-05:00",
    "estimated_end_date": "2022-04-11T00:00:00-04:00",
    "actual_end_date": "2022-03-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-12T02:08:11-04:00",
    "status": "resolved",
    "en_comments": "Issue has been resolved.",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "SODIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "CHLORURE DE SODIUM INJECTABLE USP",
    "fr_drug_common_name": "CHLORURE DE SODIUM INJECTABLE USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 ML (4:1)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 152006,
    "drug": {
      "current_status": "MARKETED",
      "id": 52223,
      "drug_code": 94453,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262116,
          "ingredient": {
            "id": 1558,
            "ingredient_code": 4732,
            "en_name": "ADENOSINE",
            "fr_name": "Adénosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02457482",
      "brand_name": "ADENOSINE INJECTION",
      "brand_name_fr": "ADÉNOSINE INJECTABLE",
      "descriptor": "12 MG/ 4 ML PREFILLED SYRINGE. SINGLE USE.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113219001"
    },
    "created_date": "2021-12-31T17:32:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457482",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "C01EB",
    "atc_description": "OTHER CARDIAC PREPARATIONS",
    "estimated_end_date": "2022-02-15T00:00:00-05:00",
    "actual_start_date": "2021-12-31T00:00:00-05:00",
    "actual_end_date": "2022-02-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-02-04T20:10:10-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we will be encountering a supply interruption on our Adenosine Injection 3 mg/mL prefilled syringe 4 mL effective today, December 31, 2021 until February 15, 2022. Our Adenosine Injection 3 mg/mL prefilled syringe 2 mL format is available for substitution.",
    "fr_comments": "Au nom de Fresenius Kabi Canada, j’ai le regret de vous aviser qu’en raison de circonstances imprévues, nous allons éprouver une interruption d’approvisionnement qui va toucher notre préparation d’Adénosine injectable, 3 mg/mL, seringues préremplies de 4 mL et ce du, 31 décembre 2021 et jusqu’au 15 février 2022. tre préparation d’Adénosine injectable, 3 mg/mL, seringues préremplies, 2 mL est disponible en guise de substitut.",
    "en_drug_brand_name": "ADENOSINE INJECTION",
    "en_drug_common_name": "Adenosine Injection  3 mg/mL prefilled syringe 4 mL",
    "fr_drug_brand_name": "Adénosine injectable",
    "fr_drug_common_name": "Adénosine injectable,  3 mg/mL, seringues préremplies, 4 mL",
    "en_ingredients": "ADENOSINE",
    "fr_ingredients": "Adénosine",
    "drug_strength": "3MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "4 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 152009,
    "drug": {
      "current_status": "MARKETED",
      "id": 14780,
      "drug_code": 75142,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255308,
          "ingredient": {
            "id": 2208,
            "ingredient_code": 11448,
            "en_name": "BLEOMYCIN",
            "fr_name": "Bléomycine (Sulfate de bléomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02265982",
      "brand_name": "BLEOMYCIN FOR INJECTION",
      "brand_name_fr": "BLÉOMYCINE POUR INJECTION",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133328001"
    },
    "created_date": "2021-12-31T17:34:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02265982",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "L01DC",
    "atc_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
    "anticipated_start_date": "2022-02-02T00:00:00-05:00",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-13T21:30:28-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Bleomycin for Injection, 15 Units, SD Vial, 10 mL effective February 2, 2022 until March 6, 2022. Pfizer is an alternate supplier of Bleomycin for Injection and have been informed of our impending supply interruption.",
    "fr_comments": "Au nom de Fresenius Kabi Canada, j’ai le regret de vous aviser qu’en raison d’un retard de production, nous allons éprouver une interruption d’approvisionnement qui va toucher notre préparation de Bléomycine pour injection, 15 unités, fioles DU, 10 mL du 2 février 2022 et jusqu’au 6 mars 2022. Pfizer étant un autre fournisseur de Bléomycine pour injection, nous l’avons informé de notre situation imminente d’interruption d’approvisionnement.",
    "en_drug_brand_name": "BLEOMYCIN FOR INJECTION",
    "en_drug_common_name": "Bleomycin for Injection,  15 Units, SD Vial, 10 mL",
    "fr_drug_brand_name": "Bléomycine pour injection",
    "fr_drug_common_name": "Bléomycine pour injection, 15 unités, fioles DU, 10 mL",
    "en_ingredients": "BLEOMYCIN",
    "fr_ingredients": "Bléomycine",
    "drug_strength": "15UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAPLEURAL\r\nINTRAMUSCULAR\r\nINTRAPLEURAL\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntrapleurale\r\nIntramusculaire\r\nIntrapleurale\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]